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Abstract
Bacterial meningitis remains one of the deadliest infectious diseases in the African meningi-
tis belt. It is defined as an acute inflammation of the meninges, the protective membranes
that cover the brain and spinal cord. This deadly disease has different serogroups with ge-
ographical distribution and epidemic potential varying amongst each serogroup. To date,
six of these serogroups have been identified as causative agents of epidemics. The effect of
this disease cannot be ignored due to its high morbidity and mortality; however, vaccination
has played a major role in preventing the spread of the disease in the population. The work
presented here was therefore designed to study the effect of constant and pulse vaccination in
controlling the disease in the population using a non-impulsive model and an impulsive mod-
els. The two models were analyzed qualitatively to determine the conditions for eradicating
the disease. Numerical simulation of the non-impulsive model showed that meningitis can
be effectively controlled in the population using an imperfect vaccine with an efficacy greater
than 75% and high vaccine coverage rate of at least 85%. For the impulsive model, we ob-
tain the disease-free periodic solution, and the model is locally asymptotically stable when
the threshold quantity, Rp, is less than one. Furthermore, numerical simulations showed
that final infected population size is lower when applying the impulsive vaccination strategy
compared with the scenario without vaccination. Thus, disease burden in the population
decreases with increasing vaccination pulses. Lastly, we present a deterministic model to
study the dynamics of co-infection of multiple strains (serogroup A and serogroup C) in the
presence of vaccination. For the scenario in which we set the transmission probability of a
strain to zero, our results show that the co-infection model exhibits competitive exclusion (a
strain driving the other strain into extinction when both are at endemic equilibrium). How-
ever, for the scenario in which we set the transmission probability of one strain greater than
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that of the other (transmission probability of neither strain is equal to zero), we observed a
trade-off mechanism which enables co-existence of the two strains. In this case, regardless of
the greatest reproduction number value of each strain, the strain with the highest transmis-
sion probability in co-infected individuals will dominate in the population without driving
the other strain into extinction. We further analyzed and simulated the model without co-
infection. The model exhibit competitive exclusion when R0A > R0C > 1 (strain A drives
out strain C) or when R0C > R0A > 1 (strain C drives out strain A). Additionally, our
results show that when the two strains have the same reproduction number at their endemic
state, the two strains will co-exist but the dominance of a strain will depend on the initial
size of its population.
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A disease is an abnormal condition that negatively affects the structure or function of an
organism. Diseases can be caused by pathogens or by internal dysfunctions. In humans,
disease often refers to any condition that causes pain, distress, dysfunction or death to the
person affected. Diseases can be classified into two main types: infectious or non-infectious
diseases (World Health Organization, 2018a). The focus of my work is on the modeling of
infectious diseases. Infectious diseases, also known as transmissible diseases, are diseases
caused by microorganisms such as bacteria, viruses, fungi or parasites. Infectious diseases
can be spread directly or indirectly from one person to another. Various types of infectious
diseases include but are not limited to meningitis, influenza, malaria, measles, tuberculosis,
and human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS).
Infectious diseases are a leading cause of illness and death worldwide. Globally, infections
cause over a fifth of all deaths and a quarter of all illnesses, and this has a high burden
on poorer communities and poor countries (Bartlett et al., 2006). Developing models of
infectious disease transmission and dynamics is important in order to further enhance our
understanding of the mechanisms by which diseases spread and also to predict the future
course of an outbreak. In addition, developing such models allows us to test our under-
standing of the disease epidemiology (incidence, distribution, and control of the disease) by
comparing different model results and observed patterns, since the formulation of transmis-
sion models are based on the current understanding of the natural history of infection and
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immunity against the disease (Huppert & Katriel, 2013; May, 2004).
1.1.1 Meningitis
Meningitis is a devastating disease which remains a major public health challenge (World
Health Organization, 2018b). It is defined as an acute inflammation (swelling) of the pro-
tective membrane which covers the brain and spinal cord collectively known as the meninges
(Centers for Disease Control and Prevention (CDC), 2017; Merck Manual, 2018; Sáez-Llorens
& McCracken Jr, 2003). This deadly disease can be caused by an infection with various mi-
croorganisms such as bacteria, viruses, fungi, or protozoa. In addition, it may also result
from various non-infectious causes, such as cancers, certain medicines, head injury and brain
surgery (Centers for Disease Control and Prevention (CDC), 2017; Ginsberg, 2004; Gleissner
& Chamberlain, 2006; Mayo Clinic, 2018; Merck Manual, 2018). However, the highest global
burden among all these causes arises from bacterial meningitis (World Health Organization,
2018b). Bacterial meningitis is of significant public health importance because of its high
morbidity and mortality globally and it can give rise to epidemics depending on the type of
bacteria causing the disease (Oordt-Speets et al., 2018). As reported by Oordt-Speets et al.
(2018), bacterial meningitis can be fatal in 50% of cases if untreated. Even when diagnosed
early and treated adequately, 8 − 15% of patients die, typically within 24 and 48 hours of
symptom onset. Furthermore, 10 − 20% of the survivors are prone to permanent sequelae
(a condition which is the consequence of a previous disease or injury); these include brain
damage, hearing loss, and learning disabilities.
Bacterial meningitis can be caused by several different types of bacteria. These include
Haemophilus influenzae (H. influenzae), Streptococcus pneumoniae (S. pneumonia), Listeria
monocytogenes (L. monocytogenes), Group B Streptococcus, and Neisseria meningitidis (N.
meningitidis). Among all these types of bacteria, N. meningitidis is responsible for caus-
ing meningococcal meningitis (Centers for Disease Control and Prevention (CDC), 2019;
Rouphael & Stephens, 2012; World Health Organization (WHO), 2018). The agents respon-
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sible for bacteria meningitis vary by age group. Among neonates (new born children), most
cases of bacterial meningitis are due to Group B Streptococcus and L. monocytogenes, while
most cases in children and adults are caused by Streptococcus pneumoniae and Neisseria
meningitidis (Brouwer et al., 2010; Oordt-Speets et al., 2018). Three predominant bacterial
types are responsible for more than 70% of bacterial meningitis cases, namely, Neisseria
meningitidis, Haemophilus influenzae and Streptococcus pneumoniae (Centre for Disease
Control, 2019). In this study, our focus will be on meningococcal meningitis.
1.1.2 Meningococcal Meningitis
Meningococcal meningitis caused by N. meningitidis bacteria is of public health importance
because of its potential to cause large epidemics. N. meningitidis has 12 different serogroups,
out of which six have been identified as capable of causing an epidemic (serogroups A, B, C,
W, X and Y) (Rouphael & Stephens, 2012; World Health Organization (WHO), 2018). It is
important to note that geographical distribution and epidemic potential differs according to
each serogroup. Chapter 3 of this thesis will discuss this further.
N. meningitidis can only be found in humans and can be transmitted between humans
through throat secretions from carriers (people who carry the bacterial in their throat or
nose but are not showing symptoms) (Agier et al., 2017; Tartof et al., 2013). Close and
prolonged contact such as kissing, sneezing or coughing on someone facilitates the spread of
the disease. The incubation period ranges between 2 to 10 days (World Health Organiza-
tion (WHO), 2018). Symptoms of infections include fever, headache, appearance of rashes
and neck stiffness; if not properly managed, complications can result in deafness, vomit-
ing, inability to tolerate light and noise, and epilepsy (Van de Beek et al., 2006; World
Health Organization (WHO), 2018). Meningococcal meningitis is treatable with antibiotics
such as penicillin, ampicillin and ceftriaxone (World Health Organization (WHO), 2018); it is
also preventable via vaccination and chemoprophylaxis (World Health Organization (WHO),
2018, 2019b).
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Figure 1.1: The meningitis belt of Africa (World Health Organization, 2018b), show the
regions in the sub-Saharan Africa, with the highest rate of incidence of meningitis
Meningococcal meningitis disease was first reported in the 16th century and it was discovered
in Switzerland Geneva by physician Gaspard Vieusseux, in the year 1805. Anton Weichsel-
baum, an Austrian pathologist and bacteriologist first identified the bacterium in the spinal
fluid of a patients in 1887 Greenwood (2006); Rouphael & Stephens (2012). Identification
of the disease has increased globally over the years. Meningococcal meningitis is distributed
globally with the highest burden in the meningitis belt of Africa, which stretches from Sene-
gal to Ethiopia (Agier et al., 2017; Molesworth et al., 2002; Tartof et al., 2013) (see Figure
1.1). During the dry season in this region between December to June, there is always an
increase in the risk of meningococcal disease due to damage of the nasopharyngeal mucosa
by dust winds, cold weather and upper respiratory tract infections. In addition to these,
increased transmission of N. meningitidis may be caused by overcrowded housing. These
factors explain the large epidemics which occur during the dry season in the meningitis belt
of Africa (World Health Organization (WHO), 2019b).
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1.1.3 Literature Review
Modeling of infectious diseases
In the field of epidemiology, researchers have employed the use of mathematical modeling
to successfully reproduce the observed incidence and prevalence of many diseases, including
meningitis (Weston et al., 2018). Mathematical models allow us to infer the dynamics of
an outbreak from the current information, to forecast the future and, most importantly, to
measure the uncertainty in these predictions. In addition, mathematical models have played
a very significant role in understanding the dynamics of infectious diseases with the major
role of better exploring the effect of control strategies to mitigate diseases.
Daniel Bernoulli, a trained physician, was the first to utilize mathematical modeling for the
spread of a disease. In 1766, he created a mathematical model to analyze mortality due to
smallpox in England, which at that time was 1 in 14 infected individuals. This study showed
that inoculation against the virus would increase the life expectancy at birth by about three
years (Hethcote, 2000; Siettos & Russo, 2013).
Following Bernoulli, many physicians have contributed to modern mathematical epidemiol-
ogy, such as Lambert and Laplace in 1772, who followed up the work of Bernoulli by ex-
tending his model to incorporate age-dependent parameters (Lambert, 1772; Laplace, 1812;
Siettos & Russo, 2013). However, as mentioned by Siettos & Russo (2013), modeling of
infectious disease had not been developed systematically until the paper of Ross in 1911
which established modern mathematical epidemiology (Wiratsudakul et al., 2016). Ross uti-
lized the mechanistic modeling approach using a set of differential equations to estimate the
discrete-time dynamics of malaria through mosquito-borne pathogen transmission (Smith
et al., 2012). After the work of Ross, the number of models developed to describe the spread
of disease in populations has been rapidly increasing. Among the most acclaimed of these
were McKendrick and Kermack, whose paper titled “A contribution to the Mathematical
Theory of Epidemics” published in 1927, founded deterministic compartmental epidemic
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modeling (Kermack & McKendrick, 1927, 1932, 1933). Models in which the values of the
dependent variables of the system are determined by the parameters of the model are called
deterministic model. The authors present a simple deterministic compartmental model which
successfully mimics the dynamics of many recorded epidemics (Brauer et al., 2001).
Over the years, mathematicians, biologists, physicians, epidemiologists, and others have con-
tributed to the maturing discipline of mathematical epidemiology. This includes the use of
a mathematical modeling approach in studying the effect of different control measures such
as vaccination, treatments, and isolation, just to mention a few, on eradicating disease in
the population. Numerous researchers have explored different methodologies and several ap-
proaches have been proposed for studying and answering different questions on the dynamics
of diseases. As mentioned by Siettos & Russo (2013), these encompass three general cate-
gories of mathematical models, namely: (1) statistical methods for surveillance of outbreaks
and identification of spatial patterns in real epidemics, (2) mathematical models within the
context of dynamical systems (also called state-space models) used to forecast the evolu-
tion of a “hypothetical” or on-going epidemic spread, and (3) machine learning or expert
methods for the forecasting of the evolution of an ongoing epidemic (Siettos & Russo, 2013).
The above three categories also have different sub-models which have been used by many
researchers in various studies. For instance, sub-models of state-space models include de-
terministics models, stochastic models, complex networked models and agent-based models
(Siettos & Russo, 2013).
In this thesis, I focus on the use of deterministic models. These describe the dynamics of
epidemics within human populations. Generally, deterministic models have been used in
various epidemiological studies, including models with age-structures where the population
is stratified into age groups in order to investigate the effect of control measures on the most
infected groups in the population (Agusto et al., 2016; Del Valle et al., 2013; Forouzannia &
Gumel, 2014; Hogan et al., 2016; Zibolenová et al., 2016). Also, some studies have explored
the use of deterministic models in investigating the dynamics of co-infection of different dis-
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eases such as tuberculosis - HIV, malaria-HIV, malaria-meningitis, to mention a few (Aldila
& Agustin, 2018; Awoke & Kassa, 2018; Mutua et al., 2015; Osman & Makinde, 2018; Slater
et al., 2013). In addition, co-infection of multiple strains of the same pathogen has been
studied using deterministic models, for example Agyingi et al. (2016); Ahn et al. (2014);
Garmer et al. (2015); Orwa et al. (2019); Qiu et al. (2013). The next sub-section focuses
specifically on a review of the literature for the mathematical modeling of meningitis.
Modeling of Meningitis
Mathematical models have helped in understanding the spread and control of many infectious
diseases, including meningitis. Over the years, many researchers have worked on the deadly
disease Neisseria meningitidis, using various approaches to explore disease dynamics and
the control measure suitable for mitigating the disease in populations. I focus here on a few
examples of these studies.
Irving et al. (2012) employed deterministic compartmental models to investigate how well
simple compartmental models can qualitatively capture the patterns of disease observed in
the meningitis belt of Africa. Their results showed that seasonal variation of transmission is
capable of accounting for the complex and irregular epidemics of meningococcal meningitis.
This indicates that the frequent but irregular epidemics could be the result of interaction
between temporary immunity and seasonal variation in disease transmissibility. In addition,
their results suggest that population immunity is an important factor to include in models
trying to predict meningitis epidemics.
Another study of the dynamics of meningococcal meningitis in this region is that of Broutin
et al. (2007). The authors present a comparative study of the dynamics of meningococcal
meningitis across nine African countries, by utilizing some mathematical tools to time series
analysis and wavelet method to better understand meningococcal meningitis evolution in
time and space. Their results highlight the strong interest and the necessity of a global survey
of meningococcal meningitis in order to predict and prevent large epidemics by adapted
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vaccination strategy. In addition, they further suggest the possibility of controlling the
infectious disease by international cooperation in public health and cross disciplinary studies.
An age-structured deterministic model was formulated by Martcheva & Crispino-O’Connell
(2003), to better understand the dynamics of meningococcal infection. The authors used
the model to study the conditions for the stability of the disease-free steady state which im-
plies an extinction of the disease in the population. They further established the condition
for the existence of an endemic state (the persistence of a disease in a given population).
The study results are applied to identify the contribution of the carriers to the transmission
of meningococcal disease in the population. Similarly, Coen et al. (2000) employed deter-
ministic compartmental models to fit age-structured data sets of nasopharyngeal carriage
of meningococci, Neisseria lactamica (LC) and meningococcal disease. Their results show
that the model most consistent with the available data sets is the one where LC inhibits
meningococcal disease. This model is also consistent with the hypothesis that Neisseria
lactamica acts as a natural immunogen against meningococcal disease.
Deterministic modeling has also been used in studying the effect of control measures for mit-
igating diseases in a given population. Among many other studies is a study by Asamoah
et al. (2018). The authors presents a nonlinear deterministic model with time-dependent
controls to describe the dynamics of bacteria meningitis in a population. Their results show
that carrier individuals have a higher chance of spreading the infection than infected in-
dividuals with clinical symptoms because of restriction to bed during the acute phase of
infection. In addition, numerical simulation of their optimal control problem demonstrates
that combination of both vaccination and other intervention such as treatment and pub-
lic health education are the best control strategies to control bacterial meningitis in the
population. Similarly, Agusto & Leite (2019) presents a deterministic model for Neisseria
meningitidis with an imperfect vaccine. In this study, sensitivity analysis suggests facial
masks and vaccination as the parameters whose variability has the strongest impact on the
disease reproduction number (the number of cases one infected individual generates on av-
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erage over the course of the infectious period in a susceptible population). Using these two
parameters as time-dependent control variables, Agusto & Leite (2019) shows that the two
controls prevent more infections at low costs. In addition, their results show an inverse rela-
tionship between the use of facial masks and vaccine (meaning that, when the use of vaccine
is high, the use of facial masks is low and vice versa).
Miller & Shahab (2005) carried out a review on the cost effectiveness of immunization strate-
gies for the control of epidemic meningococcal meningitis. They access seven economic stud-
ies on the use of polysaccharide vaccination strategies in order to highlight the relevant
epidemiological and economical issues surrounding the decisions for their use. Five of the
seven studies were based in Africa, the region with the highest annual incidence rates. Their
studies established that vaccination against meningococcal disease during outbreaks is sub-
optimal due to inability to rapidly immunize populations in the poor areas. Their results
further show that economic analyses of mass immunization campaigns and routine vaccina-
tion suggest that routine use of meningococcal vaccines for preventive strategies could be
within the range of cost-effective public health interventions in areas where the disease is
endemic.
Among many studies that have considered the use of vaccination in controlling Neisseria
meningitidis, to the best of our knowledge no studies have explored the use of pulse vaccina-
tion in the eradication of this disease in the population. Pulse vaccination strategy involves
repeated vaccination at specific times of at-risk groups of certain age in order to eradicate
an epidemic (Gao et al., 2006b; Nokes & Swinton, 1995, 1997). Over the years, this is gain-
ing prominence as a strategy for the elimination of childhood viral infectious diseases such
as parotitis, smallpox, measles, hepatitis and phthisis (Agur et al., 1993; Ramsay et al.,
1994; Shulgin et al., 1998; Zou et al., 2009). Pulse vaccination remains an effective way of
controlling the transmission of diseases with some practical advantages, (Agur et al., 1993;
d’Onofrio, 2005; Gao & Chen, 2005; Shulgin et al., 1998; Stone et al., 2000; Zou et al., 2009).
For example, the use of annual immunization days was found to be successful in eradicat-
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ing measles in the Gambia between the year 1967 and 1972 (Moneim & Greenhalgh, 2005;
Williams & Hull, 1983). South and Central America have successfully applied pulse vaccina-
tion strategy to poliomyelitis (Moneim & Greenhalgh, 2005; Sabin, 1991), and this method
is now used in Brazil and is easier to arrange and more effective than constant vaccination
strategy (Moneim & Greenhalgh, 2005). Pulse vaccination is sometimes more effective than
constant vaccination (Li & Yang, 2011; Li & Cui, 2009; Röst & Vizi, 2014; Shulgin et al.,
1998), hence our goal in this thesis include the investigation of the dynamics of an impulsive
model with pulse vaccination. Impulsive models are models which allows impulsive effects
such as time delay. Chapter two of this thesis focuses on the use of an impulsive model in
studying the effect of pulse vaccination in controlling meningitis in the population. To the
best of our knowledge, this study is the first work to consider pulse vaccination strategy on
meningitis in Nigeria.
A study by Maseno (2011) developed a mathematical model to study the dynamic behavior
of malaria-meningitis co-infection among children under the age of five years, with an as-
sumption of no simultaneous infection of host with the two diseases. Their results deduce
that a reduction in malaria infection cases would reduce the number of new co-infection
cases.
While several studies such as that by Maseno (2011) have been done on co-infection of other
diseases, no work has been done on the modeling of multiple strains of Neisseria meningitidis
in Nigeria. Due to the existence of multiple invasive strains in the meningitis belt of Africa,
we develop a mathematical model to study the dynamic of multiple strain in the presence
of vaccination. This is presented in the third chapter of this thesis.
1.1.4 Research Aim and Objectives
The main aim of this thesis is to study the effect of vaccination in controlling meningitis,
specifically utilizing data from Nigeria to parameterize the model. This includes the role of
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vaccination in the strain replacement of meningitis A by meningitis C in Nigeria. To help
us achieve the main aim of this study, the following objectives were sought:
(i) To study the effect of constant and pulse vaccination in controlling meningitis using an
ordinary differential equation model (which we will refer to as the non-impulsive model)
and an impulsive differential equation model (which we will refer to as the impulsive
model). We use the non-impulsive model to study the effect of vaccination when a fixed
proportion of the susceptible individuals are vaccinated, while the impulsive model is
used when vaccination is administered impulsively at other regular or irregular times.
(ii) To study the dynamics of meningitis A and meningitis C in the presence of vaccination
under different scenarios. The scenarios considered in this thesis include the more
generalized model with co-infected individuals of strain A and C. Since there is no
data on the ability of individuals to be infected with the two strain at the same time,
we consider the case whereby assumed co-infected individuals can only transmit the
strain with the highest transmission probability. Also, we considered the model without
individuals co-infected with the two strains.
1.1.5 Research questions
The above aim and objectives are channeled to answer the following questions:
(i) What are the conditions for controlling meningitis in the population, in the presence
of imperfect vaccine (Chapter 2) ?.
(ii) In the presence of multiple strains (serogroup A and serogroup C) in the population,
does competitive exclusion occur (will a strain drive out the other strain when both
are endemic) (Chapter 3) ?
(iii) Under what conditions will the two strains co-exist (if there is co-existence of strain
A and strain C in the population), and which strain will dominate in the presence of
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co-existence of the two strains (Chapter 3) ?
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Chapter 2
Modeling the Effect of Vaccination on Neisseria
meningitidis in Nigeria
2.1 Introduction
Meningitis is an acute inflammation of the protective membrane covering the spinal cord
and the brain which is collectively known as the meninges (Centers for Disease Control and
Prevention (CDC), 2017; Sáez-Llorens & McCracken Jr, 2003). Meningitis is caused by an
infection with microorganisms such as bacteria, viruses, fungi and protozoa and it may also
result from various non-infectious causes (Centers for Disease Control and Prevention (CDC),
2017; Ginsberg, 2004; Gleissner & Chamberlain, 2006; Mayo Clinic, 2018). Several different
bacteria are capable of causing meningitis, these include Neisseria meningitidis which causes
Meningococcal Meningitis (Rouphael & Stephens, 2012; World Health Organization (WHO),
2018). N. meningitidis has 12 different serotypes, out of which six has been identified capable
of causing an epidemic namely serotypes A, B, C, W, X and Y (Rouphael & Stephens, 2012;
World Health Organization (WHO), 2018).
N. meningitidis can only be found in humans, and can be transmitted from human to human
through throat secretions from carriers (people who carry the bacterial in their throat or
nose but are not showing symptoms) (Agier et al., 2017; Tartof et al., 2013). Also, close and
prolonged contact such as kissing, sneezing or coughing on someone, facilitates the spread of
the disease. The incubation period ranges between 2 to 10 days (World Health Organization
(WHO), 2018). The symptoms are often characterized by fever, headache, appearance of
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rashes and neck stiffness, but if not properly managed, complications can result in deafness,
vomiting, inability to tolerate light and noise and epilepsy (Van de Beek et al., 2006; World
Health Organization (WHO), 2018). Meningococcal meningitis is treatable with antibiotics
such as penicillin, ampicillin and ceftriaxone (World Health Organization (WHO), 2018); it is
also preventable via vaccination and chemoprophylaxis (World Health Organization (WHO),
2018).
The first outbreak of meningococcal meningitis was discovered in Switzerland Geneva in
1805 (Greenwood, 2006; Rouphael & Stephens, 2012). The disease has since spread globally
with the highest burden in the meningitis belt in Africa, which stretches from Senegal to
Ethiopia (Agier et al., 2017; Molesworth et al., 2002; Tartof et al., 2013). The disease
outbreaks usually occur during dry season with no rain; in Nigeria, outbreaks occur during
the Harmanttan season when dry wind from the Sahara Desert blows downward to the Gulf of
Guinea. However disease incidence often declines with the onset of rains in the raining season
(Agier et al., 2013; Moore, 1992). Between January 1996 to June 1996 a severe meningitis A
outbreak occurred in Nigeria with 109,580 cases and 11,717 deaths, with 10.69% case fatality
rate (World Health Organization (WHO), 2017). Since 2010 Nigeria has been carrying out
mass immunization campaigns with MenAfriVac against meningitis A serogroup. However,
since 2013 Nigeria has been experiencing large outbreaks of meningitis C. In 2015, over 2500
cases of the disease were reported in the country (World Health Organization (WHO), 2017).
Another outbreak occurred in 2017 in Nigeria with over 9,902 cases and 602 deaths (Nigeria
Centre for Disease Control (NCDC), 2017).
Early detection of cases and emergency mass vaccination of the population have been the
approach for controlling meningitis epidemic (LaForce et al., 2007). Provision of vaccine
against this disease has been shown to be effective in preventing the disease in adult and
children. There are two types of vaccine currently used in Africa, these are conjugate and
polysaccharide vaccines. The conjugate vaccines are used for routine immunization schedules,
preventive campaign and outbreak response (World Health Organization (WHO), 2018).
14
These type of vaccine include monovalent A, monovalent C and tetravalent A, C, Y, W.
Conjugate vaccines confer long-lasting immunity, they prevent carriage and also induce herd
immunity (World Health Organization (WHO), 2018). Polysaccharide vaccines on the other
hand are either bivalent which prevents against (serogroups A and C), trivalent vaccine
which prevents against (serogroups A, C, and W) or a tetravalent vaccine which prevents
against (serogroups A, C, Y, and W) (World Health Organization (WHO), 2018). They
have been available and in use since the 1970s (Centers for Disease Control and Prevention
and others, 2012) and they have limited efficacy (LaForce et al., 2007; Reingold et al.,
1985) they do not decrease carriage and they do not confer herd immunity (Hassan-King
et al., 1988; LaForce et al., 2007). Recently, a first-in-man phase 1 single-centre, double-
blind, randomised, controlled study in healthy adults was carried out to assess the effects of
NmCV-5 pentavalent meningococcal conjugate vaccine which targets the A, C, Y, W, and
X serogroups (Chen et al., 2018).
In this study, we present a mathematical model to study the effect of constant and pulse
vaccination in controlling meningitis in the population using an ordinary differential equa-
tion and an impulsive differential equation respectively. Pulse vaccination strategy involves
repeated vaccination at specific times of at risk groups say of certain age in order to eradicate
an epidemic (Gao et al., 2006a; Nokes & Swinton, 1995, 1997). This is gaining prominence as
a strategy for the elimination of childhood viral infectious diseases such as parotitis, small-
pox, measles, hepatitis and phthisis (Agur et al., 1993; Ramsay et al., 1994; Shulgin et al.,
1998; Zou et al., 2009).
Pulse vaccination remains an effective way of controlling the transmission of diseases with
some practical advantages (Agur et al., 1993; d’Onofrio, 2005; Gao & Chen, 2005; Shulgin
et al., 1998; Stone et al., 2000; Zou et al., 2009). For instance, the use of annual immunization
days was found to be successful in eradicating measles in the Gambia between 1967 and 1972
(Moneim & Greenhalgh, 2005; Williams & Hull, 1983). South and Central America have
15
successfully applied pulse vaccination strategy to poliomyelitis (Moneim & Greenhalgh, 2005;
Sabin, 1991), and this method is now used in Brazil and is easier to arrange and more effective
than constant vaccination strategy (Moneim & Greenhalgh, 2005). Pulse vaccination has
been used in Africa recently although with only partial success (Moneim & Greenhalgh,
2005). Pulse vaccination sometimes is more effective than constant vaccination (Li & Yang,
2011; Li & Cui, 2009; Röst & Vizi, 2014; Shulgin et al., 1998) hence our goal in this chapter is
to investigate the dynamics of the impulsive model with pulse vaccination. To the best of our
knowledge, this study is the first work to consider pulse vaccination strategy on meningitis
in Nigeria.
This chapter is organized as follows: the model formulation with constant vaccination strat-
egy is presented in Section 2.2. In Section 2.3, we analyze the stability of model with constant
vaccination and determined the reproduction number. The sensitivity analysis of the model
with constant vaccination is investigated in Section 2.3.4. The impulsive model, existence of
a periodic solution, and the stability of the model are presented in Section 2.4. We illustrate
the result of the impulsive model using numerical simulations in Section 2.5. The results of
the study are discussed in Section 2.6.
2.2 Formulation of model with constant vaccination
First, we study the effect of constant vaccination strategy using the N. meningitidis model
developed by Agusto & Leite (2019). The population is divided into Susceptible (S), Vacci-
nated (V ), Carrier (C), Infected (I), and Recovered (R) classes, where the total population
is given as
N = S + V + C + I +R.
Nigeria is Africa’s most populous country. The Nigerian population since the 1950s has been
trending exponentially up due to very high birth rates Wikipedia (2019). The susceptible
class is populated by birth at rate πN since the population is growing exponentially. Alos,
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the population increase in number by vaccine waning at rate ω from the vaccinated class, and
by loss of immunity of the recovered individuals at the rate κ. The susceptible population
is reduced by natural death at rate µ, by constant vaccination to the vaccinated class at
rate ν and by infection to the carrier class λ. The quantity λ is the infection function of the





Hence, the rate of change of the susceptible population at any time t is given as:
dS
dt
= πN + ωV + κR− λS − (ν + µ)S. (2.1)
The vaccinated population is obtained as a result of vaccination of the susceptible class at
a rate ν. Although, there are various types of vaccine, namely conjugate, polysaccharide,
and pentavalent (in trial) vaccines with different efficacy and waning, we assume in this
study a generic vaccine with generic efficacy and waning since all the vaccines protect the
population with different efficacies and waning which our model is able to capture by using
the appropriate values for the parameters corresponding to vaccine efficacy and vaccine
waning. However, since the vaccine is imperfect, a fraction (1 − ε) of the vaccinated class
is infected, where ε is the vaccine efficacy. ε = 1 implies the vaccine is 100% effective at
preventing infection. Therefore, the vaccinated class is depopulated via natural death at




= νS − (1− ε)λV − (ω + µ)V. (2.2)
Carrier class derived its population from infection coming from both susceptible and vac-
cinated classes and depopulated by disease progression to the infected class at rate σ, by
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recovery to the recovered class at rate γC , and by natural death at rate µ. The carrier
population is given below as
dC
dt
= λS + (1− ε)λV − (σ + γC + µ)C. (2.3)
The infected population is generated following the progression from the carrier class. This
class is reduced by recovery at rate γI to the recovered class, by natural death at rate µ, and




= σC − (γI + µ+ δ)I. (2.4)
The recovered class gets its population as a result of recoveries from both carrier and infected
classes at rate γC and γI respectively. Depopulation of this class result from loss of immunity
at rate κ and by natural death at rate µ. The recovered population is given as
dR
dt
= γCC + γII − (µ+ κ)R. (2.5)
The overall processes explained above transforms into the following systems of ordinary
differential equation given as:
dS
dt
= πN + ωV + κR− λS − (ν + µ)S (2.6)
dV
dt
= νS − (1− ε)λV − (ω + µ)V
dC
dt
= λS + (1− ε)λV − (σ + γC + µ)C
dI
dt
= σC − (γI + µ+ δ)I
dR
dt
= γCC + γII − (µ+ κ)R.
The model flow-diagram is given in Figure 2.1 and model the variables and parameters
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descriptions are given in Table 2.1.
Figure 2.1: Flow diagram of the meningitis model (2.6).
Adding components of the meningitis model (2.6) gives
dN(t)
dt
= (π − µ)N − δI (2.7)
Given nonnegative initial numbers of individuals in each class with N(0) > 0, Equation (2.7)












ω Vaccine waning rate
β Transmission probability
η Disease modification parameter
γC Recovery rate of carrier
γI Recovery rate of infected
σ Progression rate of carrier to infected
κ Immunity waning rate
µ Natural death rate
δ Disease induced death rate
Table 2.1: Description of the variables and parameters of the meningitis model (2.6).
2.3 Analysis of the meningitis model
It is easier to analyze the model in terms of proportions, so we make the following transfor-
mation S = sN , V = vN , C = cN , I = iN , and R = rN , leading to the system (2.8) below
while still using the same variable names as model (2.6) above.
dS
dt
= π − πS + ωV + κR− β(ηC + I)S − νS + δSI
dV
dt
= νS − β(1− ε)(ηC + I)V − (π + ω)V + δV I
dC
dt
= β(ηC + I)[S + (1− ε)V ]− (π + σ + γC)C + δCI
dI
dt
= σC − (π + γI + δ)I + δI2
dR
dt
= γCC + γII − (π + κ)R + δRI.
(2.8)
20
The total population in (2.7) is now given as
dN(t)
dt
= (π − µ− δi)N (2.9)





(S(t), V (t), C(t), I(t), R(t)) ∈ R5+ : 0 ≤ S(t), V (t), C(t), I(t), R(t) ≤ 1
}
.
The region Ω is positively invariant.
2.3.1 Stability of the disease-free equilibrium (DFE)
The meningitis model (2.6) has a disease free equilibrium obtained by setting the right-hand
sides of the equations in the model to zero when C = I = R = 0. Thus, the disease free
equilibrium is given by
E0 = (S∗, V ∗, C∗, I∗, R∗) =
(
π + ω
π + ν + ω
,
ν
π + ν + ω
, 0, 0, 0
)
. (2.10)
The stability of the dfe E0 can be established using the next generation operator method (P.
Van den Driessche and J. Watmough, 2002) with C and I as the infected compartment.
The F and V matrices for the transmission matrix (new infection) and the transition matrix
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(remaining transfer terms) are given respectively by
F =

βη [S∗ + (1− ε)V ∗]
N∗








where k3 = π+ σ+ γC +µ and k4 = π+ γI +µ+ δ. Thus, the reproduction number is given
as
R0 = ρ(FV −1) =
β[S∗ + (1− ε)V ∗](ηk4 + σ)
k3k4
(2.11)
where ρ is the spectral radius (highest eigenvalue) of the matrix FV −1.
Hence, the following result is established.
Theorem 1 The meningitis model (2.8) disease-free equilibrium E0 is locally-asymptotically
stable (LAS) if R0 < 1 and unstable if R0 > 1.
The basic reproduction number R0 measures the average number of new infections generated
by a single infected person during his or her infectious period in a population that is fully
susceptible. Thus, the epidemiological implication of Theorem 1 is that meningitis will be
controlled in the population whenever R0 < 1 if the initial sizes of the population of the
model are in the basin of attraction of the DFE (E0).
2.3.2 Existence and stability of boundary equilibria (EEP)
Here we will establish the conditions for the existence of an equilibrium for which the disease
is endemic in the population. Let
E1 = (S∗∗, V ∗∗, C∗∗, I∗∗, R∗∗)
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denote the infection equilibria of the meningitis model (2.8). Setting the right-hand side of
Equation (2.8) to zero and solving for S∗∗, V ∗∗, C∗∗, R∗∗ in terms of I∗∗ we have
S∗∗ = −(κγCδ(I∗∗)2 + πσδI∗∗ − κγCk3I∗∗ − κγIσI∗∗ − πσk4)(−EEβηk3I∗∗
+EEβηδ(I∗∗)2 − EEβσI∗∗ − k1σ + σδI∗∗)/[(δI∗∗ − k4)(σδ2(I∗∗)3EEβη
−σδEEβηk3(I∗∗)2 − σ2δEEβ(I∗∗)2 − σ2δk1I∗∗ − βηk3δσ(I∗∗)2 + βηδ2σ
−ωσ2ν(I∗∗)3 − βσ2δ(I∗∗)2 − νσ2δI∗∗ + 2β2ηk3EEσ(I∗∗)2 + βηk3k1σI∗∗
+β2η2δ2EE(I∗∗)4 + β2η2k23EE(I
∗∗)2 − 2β2η2k3EEδ(I∗∗)3
−2β2ηδEEσ(I∗∗)3 + β2σ2EE(I∗∗)2 + βσ2k1I∗∗ − βηδk1σ(I∗∗)2
+νσEEβηk3I
∗∗ − νσEEβηδ(I∗∗)2 + νσ2EEβI∗∗ − πσ2δI∗∗
+πσEEβηk3I
∗∗ − πσEEβηδ(I∗∗)2 + πσ2EEβI∗∗ + πσ2k1 + νσ2k1 + σ2δ2(I∗∗)2)]
V ∗∗ = νσ(πσδI∗∗ − κγCk3I∗∗ + κγCδ(I∗∗)2 − κγIσI∗∗ − πσk4)
/[(δI∗∗ − k4)(−EEσδβηk3(I∗∗)2 + σδ2EEβη(I∗∗)3 − σ2δEEβ(I∗∗)2
−σ2δk1I∗∗ − βηk3δσ(I∗∗)2 + βηδ2σ(I∗∗)3 − ωσ2ν − βσ2δ(I∗∗)2
−νσ2δI∗∗ + 2β2ηk3EEσ(I∗∗)2 + βηk3k1σI∗∗ + β2η2δ2EE(I∗∗)4 + β2η2k23EE(I∗∗)2
−2β2η2k3EEδ(I∗∗)3 − 2β2ηδEEσ(I∗∗)3 + β2σ2EE(I∗∗)2 + βσ2k1I∗∗ − βηδk1σ(I∗∗)2
+νσEEβηk3I
∗∗ − νσEEβηδ(I∗∗)2 + νσ2EEβI∗∗ − πσ2δI∗∗ + πσEEβηk3I∗∗
−πσEEβηδ(I∗∗)2 + πσ2EEβI∗∗ + πσ2k1 + νσ2k1 + σ2δ2(I∗∗)2)]
C∗∗ = (k3 − δI∗∗)I∗∗/σ
R∗∗ = (γCk3 + γIσ − γCδI∗∗)I∗∗/(σ(k4 − δI∗∗)),
23
where EE = 1− ε. Substituting these into the fourth equation of (2.8) and equating to zero








∗∗ +A0] = 0. (2.12)
The coefficients A0, · · · , A7 of the polynomials are given in Appendix A.1. Clearly, I∗∗ = 0 is
a solution. The coefficient A7 is positive while the sign of A0 coincides with that of (1−R0),
so that if R0 > 1, A0 > 0, in which case, there is at least one sign change in the sequence of
coefficients (A7, · · · , A0). Hence, by Descartes Rule of signs, there exists at least one positive
real root for (2.12) aside from the root I∗∗ = 0, whenever R0 > 1. This leads to the following
lemma.
Lemma 1 The meningitis model (2.8) has at least one endemic equilibrium whenever R0 >
1.
2.3.3 Parameter estimation
The parameter values used in this study are taken from Agusto & Leite (2019). They em-
ployed three strategies for estimating the model parameter values. These include gathering
of parameter values from literature such as vaccine efficacy 85%, vaccine waning rate 1/5
day−1, and disease induced death rate 0.1923 year−1. For parameters not found in the liter-
ature, the authors estimated their values when possible. For instance, natural death rate µ
is estimated as µ = 1/56 per year, where 56 years is the life expectancy in Nigeria. Lastly,
for the parameters that could not be obtained by neither of the two strategies (literature
and estimation), the authors fitted the parameters based on the 2017 Nigerian meningitis
outbreak data which was obtained from the Nigeria Centre for Disease Control (NCDC)
for weeks 5-27. It was noted that, since the data set has no public health interventions
such as vaccination, the authors used the model Equation(2.6) (without implementation of
public health interventions such as vaccination or facial masks) to reflect these conditions in
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other to proceed with the parameterization. The parameters fitted are given as β = 0.3345,
γC = 0.1118, γI = 0.128, σ = 0.0438 and κ = 0.0032. Nigeria’s growth rate per year is 0.025,
that is π−µ = 0.025 from (2.7). Unlike Agusto & Leite (2019), we estimate the recruitment
rate π as π = 0.025 + µ = 0.02505 per year.
The cumulative number of cases for the 2017 meningitis outbreak in Nigeria from week 5
through 27 as presented by Agusto & Leite (2019) is depicted in Figure 2.2. The authors
used these data to parameterize the model.
Figure 2.2: Cumulative number of cases for the 2017 meningitis outbreaks in Nigeria as presented
in Agusto & Leite (2019).
2.3.4 Sensitivity analysis of the model with constant vaccination
Next, we carry out a sensitivity analysis of the model in order to determine the influence of
each parameters on the reproduction number R0. Following McLeod et al. (2006), we use
the normalized forward sensitivity index. The normalized forward sensitivity index of the








where p is respective parameters in the reproduction number R0. The parameter values used
are presented in Table 2.2. The parameters value were determined by fitting the data from
the 2017 meningitis outbreak in Nigeria. The results from the analysis depicted in Figure
2.2 shows that the transmission probability (β), disease modification parameter (η), recovery
rate of carrier (γC) and vaccine efficacy (ε) have the most impact on the reproduction number
R0, and can be used as means to control disease burden in the community.
Parameter Values Sensitivity index
π 0.02505 year−1 −0.0980
ν 0.4868 day−1 −0.439
ε 0.85 −1.388
ω 0.200 day−1 0.390






σ 0.0438 day−1 −0.130
κ 0.0032 day−1 N/A
µ 0.0179 year−1 N/A
δ 0.1923 year−1 −0.063
Table 2.2: Parameter values of the model meningitis and respective sensitivity index (2.6). All
parameter values are taken from Agusto & Leite (2019).
For instance, the transmission probability (β) which has a sensitivity index of 1.00 has a
positive impact on the reproduction number and 10% increase in β will lead to a 10% increase
in disease burden. While vaccine efficacy (ε) with sensitivity index of −1.388 will reduce
the disease burden to about 14% if the vaccine efficacy was increased by 10%. Similarly, the
disease burden will decrease by 6.2% if the recovery rate, γC , among the carrier population
with sensitivity index −0.619 was increased by 10%. See Figure 2.3 for the bar plot of the
sensitivity indices showing the effect of the various model parameters on the reproduction
number.
26








Disease induced death rate
Recovery rate for carrier
Recovery rate for Infected
Recruitment rate
Figure 2.3: Sensitivity index of the model (2.6) using the baseline parameter value in Table 2.2.
Next, we vary in Figures 2.4 and 2.5 the values of the three vital parameters with the highest
sensitivity indices, namely the transmission probability (β), recovery rate of carrier (γC) and
vaccine efficacy (ε). This enables us to further explore their impact on the reproduction
number.
We observed in Figure 2.4(a) that as the values of β increases the disease burden increase
as the values of R0 increases. It might be difficult to curtail the disease at high values of
β > 0.33 since the values of R0 are above one. Similarly in Figure 2.4(b), we see an increase
in R0 values; however, curtailing the disease might be difficult at low values of γC < 0.11.
On the other hand we see in Figure 2.4(c) that increasing values of vaccine efficacy, ε, will
reduce disease burden, that is lower R0 values. In fact very low values of ε (say 0.25) will
reduce R0 values.
Next, we access the impact of vaccine efficacy and its coverage in eradicating the disease in
a population. Figure 2.5 shows the effect of vaccine efficacy (ε) with respect to low and high
vaccine coverage (P ) respectively. From Figure 2.5(a) we observed that the reproduction
number R0 remain below one even for very low vaccine efficacy 25% at low vaccine coverage
(P ) of 25%. Note that even though these values are below one, they are close to one and
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might not necessary guarantee disease elimination if we factor in backward bifurcation, a
phenomenon common in most disease models with vaccination. Under this phenomenon,
two stable equilibria co-exist at the disease-free equilibrium. We explore this possibility at
a later date.
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Figure 2.4: Bar plot showing the effect of the most sensitive parameters on reproduction number
R0 using: (a) The transmission probability β; (b) Vaccine efficacy ε; (c) The recovery rate of the
carrier population γC . Parameter values (ranges) used are as given in Table 2.2.
When the proportion vaccinated are increased to 85%, the values of the reproduction numbers
R0 are below one for all values of the vaccine efficacy (see Figure 2.5(b)). However, the values
are well below one R0 for higher values of the vaccine efficacy; for instance, with ε = 75%
we see a strong reduction in R0.
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In Figure 2.5(c) we vary the proportion vaccinated from 25% to 100% and keep vaccine
efficacy low at ε = 25%; we observed in Figure 2.5(b) high R0 values which are close to
one. On the other hand in Figure 2.5(d), when we set the vaccine efficacy high (ε = 85%),
R0 values are below one. We observed further that we are able to bring the reproduction
number all well below one with a vaccine efficacy of 75% and a coverage of 85%. Thus,
this aspect of the study shows the possibilities of effectively controlling the disease in the
population using an imperfect vaccine with an efficacy of > 75% and high vaccine coverage
rate of at least 85%.
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Figure 2.5: Bar plot showing the effect of vaccine efficacy (ε) with respect to coverage on the
reproduction number R0: (a) Varying vaccine efficacy at 25% coverage; (b) Varying vaccine efficacy
at 85% coverage; (c) Varying coverage at 25% vaccine efficacy; (d) Varying coverage at 85% vaccine
efficacy. Parameter values used are as given in Table 2.2.
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Thus, we conclude from these results that, having a high vaccine efficacy alone is not sufficient
to reduce the reproduction number below one but having a high vaccine efficacy together
with high coverage is sufficient to reduce the reproduction number well below one.
2.4 The Meningitis model with impulse control
In the previous section, we considered a constant vaccination where a fixed proportion of
the susceptible individuals are vaccinated. However, vaccination may be administered im-
pulsively at either regular or irregular times in order to curtail disease outbreak. Thus
leading to an impulsive system described by a system of non-autonomous impulsive differen-
tial equations (Bainov & Simeonov, 1995; Lakshmikantham et al., 1989; Smith et al., 2017).




= πN + ωV + κR− λS − µS
dV
dt
= −(1− ε)λV − (ω + µ)V
dC
dt
= λ[S + (1− ε)]V − (σ + γC + µ)C
dI
dt
= σC − (γI + µ+ δ)I
dR
dt
= γCC + γII − (µ+ κ)R

t 6= nT, n ∈ N (2.14)
subject to the impulse condition
S+ = (1− ν)S−, V + = V − + νS− t = nT, n ∈ N (2.15)
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where tk is the vaccination times which may be fixed or non-fixed; in this study we will
consider the case with fixed times. As with model (2.8) in Section 2.3, we analyze the model
in terms of proportions, using the same previous transformation S = sN , V = vN , C = cN ,
I = iN , and R = rN , leading to the impulsive system (2.16) below while still using the same
variable names as model (2.14) above.
dS
dt
= π − πS + ωV + κR− β(ηC + I)S + δSI
dV
dt
= −β(1− ε)(ηC + I)V − (π + ω)V + δV I
dC
dt
= β(ηC + I)[S + (1− ε)V ]− (π + σ + γC)C + δCI
dI
dt
= σC − (π + γI + δ)I + δI2
dR
dt
= γCC + γII − (π + κ)R + δRI.

t 6= nT, n ∈ N (2.16)
We will study (2.16) in the region
Γ =
{
(S(t), V (t), C(t), I(t), R(t)) ∈ R5+ : 0 ≤ S(t), V (t), C(t), I(t), R(t) ≤ 1
}
.
The region Γ is positively invariant which can be seen from the right-hand side of (2.16).
2.4.1 Existence and stability of disease free periodic solution
To determine the disease-free periodic solution, assume C(t) = I(t) = R(t) = 0, for t ≥ 0




= π − πS + ωV
dV
dt
= −(π + ω)V
 t 6= nT, n ∈ N (2.17)
S+ = (1− ν)S−, V + = V − + νS− t = nT, n ∈ N.
Using the fact that S(t) + V (t) = 1, system (2.17) becomes
dS
dt
= (π + ω)− (π + ω)S (2.18)
In the time interval nT ≤ t ≤ (n+ 1)T , system (2.18) has the solution
S(t) = 1 + e−(π+ω)(t−nT )(S(nT+)− 1) (2.19)
Let Sn+1 be the size of susceptible population after the (n+ 1)-th pulse, i.e. Sn+1 = S((n+
1)T+). From (2.18) we have
Sn+1 = (1− ν)(1 + e−(π+ω)T (Sn − 1)) := ψ(Sn).






If t 6= nT
S̄(t) = 1 + e−(π+ω)(t+T−(n+1)T )
[
(1− ν)(1− e−µT )
(1− (1− ν)e−(π+ω)T )
− 1
]
= 1 + e−(π+ω)(t−nT )
[
(1− ν)(1− e−(π+ω)T )




and in case t = nT, S̄(t) = S∗ = S̄((n + 1)T ), so (2.18) is periodic with period T . Thus,
the solution of (2.18) is a solution not only in the time interval [0, T ), but also for all t ≥ 0.
Hence, the solution of (2.18) in the time interval [0, T ) is
S̄(t) = 1 + e−(π+ω)(t−nT )
[
(1− ν)(1− e−(π+ω)T )




Since V (t) = 1− S(t), it follows that V̄ (t) = e−(π+ω)T
[





Further, similar to Lemma 2.2 of Gao et al. (2006a), it can be shown that (S̄(t), V̄ (t)) is
globally asymptotically stable by using stroboscopic map. Hence, we summarize this results
below as
Lemma 2 The model (2.16) has a unique disease-free periodic solution given as
S̄(t) = 1 + e−(π+ω)T
[
(1− ν)(1− e−(π+ω)T )
(1− (1− ν)e−(π+ω)T )
− 1
]
V̄ (t) = e−(π+ω)T
[




C̄(t) = 0, Ī(t) = 0, R̄(t) = 0.
From Lemma 2, system (2.16), admits the disease-free periodic solution (DFPS) (S̄(t), V̄ (t), 0, 0, 0)
on every impulsive interval [nT, (n + 1)T ]. To determine the stability of DFPS of system
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(2.16), we follow the approach in Xu et al. (2015) and define the following matrices
F =
βη[S̄ + (1− ε)V̄ ] β[S̄ + (1− ε)V̄ ]
0 0




Let A be a n× n matrix, ΦA(.)(t) be the fundamental solution matrix of the linear ordinary
differential system x′ = Ax, and ρ(ΦA(.)(w)) be the spectral radius of ΦA(.)(w). Let S =
s(t) + S̄(t), V = v(t) + V̄ (t), C = c(t), I = i(t), R = r(t). Then system (2.16) becomes
 x
′(t) = Qx(t), t 6= nT, n ∈ N





0 F − V










 , B =

−βηS̄ −βS̄ + δS̄





1− ν 0 0
ν 1 0
0 0 1




and g1 = (π + ω), g2 = (π + σ + γC), g3 = (π + γI + δ), g4 = (π + κ).
Let ΦQ(t) = (Qij)1≤i,j≤2 be the fundamental matrix of x
′(t) = Qx(t). Then Φ′Q(t) = QΦQ(t)









0 P2Φ(F−V )(T )
 .
Therefore, the stability DFPS is dependent on eigenvalues of P1e
UT and P2Φ(F−V )(T ).
The eigenvalues of P1e
UT are e−
∫ τ






























0 ωdτ + (1− ν)e−
∫ τ











We can show that ρ(P1e
U1T ) < 1. Thus, the following theorem holds.
Theorem 2 If ρ(P2Φ(F−V )(T )) < 1 holds true, then the disease-free periodic solution
(S̄(t), V̄ (t), 0, 0, 0) of system 2.16 is locally asymptotically stable.
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We denote the spectral radius as Rp = ρ(P2Φ(F−V )(T )). Note, Rp does not produce the
number of individual infected by a single infected carrier or infectious individual. Namely it
does not produce the average number of secondary infections Xu et al. (2015). However, it
works as a threshold such that the disease persists as Rp > 1 (Xu et al., 2015).
2.4.2 Persistence of the disease
Theorem 3 If Rp = ρ(P2Φ(F−V )(T )) > 1, the disease persists; namely, there exists L > 0
such that limt→∞C(t) ≥ L > 0, limt→∞ I(t) ≥ L > 0, and limt→∞R(t) ≥ L > 0.
Proof From Rp = ρ(P2Φ(F−V )(T )) > 1, we can choose small enough positive constants L, ζ1
and ζ2 such that
ρ(P2Φ(F(L,ζ1,ζ2)−V )(T )) > 1,
where
F =
βη[S̄ + (1− ε)V̄ ] β[S̄ + (1− ε)V̄ ]
0 0
 ,
and S̄ and V̄ are given by Section 2.4.1.
First we prove there exists a positive constant L such that supt→∞C(t) ≥ L > 0, supt→∞ I(t) ≥
L > 0 and limt→∞R(t) ≥ L > 0. Otherwise, there exists a t1 > 0 such that C(t) < L, I(t) <
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L, for all t ≥ t1. By the first two equations of system (2.16), we have
dS
dt
≥ π + ωV + κL− β(ηL+ L)S − πS + δSL
dV
dt
≥ −β(1− ε)(ηL+ L)V − (ω + π)V + δV L
 t 6= nT, n ∈ N (2.21)
S+ = (1− ν)S−, V + = V − + νS−, t = nT, n ∈ N
Consider the auxiliary system
dx1
dt
= π + ωV + κL− β(ηL+ L)x1 − πx1 + δx1L
dx2
dt
= −β(1− ε)(ηL+ L)x2 − (ω + π)x2 + δx2L
 t 6= nT, n ∈ N (2.22)
x+1 = (1− ν)x−1 , x+2 = x−2 + νx−1 , t = nT, n ∈ N
Using the same method as system (2.17) and the fact that x1(t) + x2(t) = 1, we obtain that
system (2.22) admits a locally asymptotically stable positive periodic solution x̄ = (x̄1, x̄2),
meanwhile limL→0(x̄1, x̄2) = (S̄, V̄ ).
Thus, there exists a positive constant L1 small enough and for any ζ1 > 0, such that x̄1 ≥
S̄ − ζ1 and x̄2 ≥ V̄ − ζ1 for L < L1. By the comparison theorem, there exists t2 ≥ t1 and
ζ2 > 0, such that S(t) ≥ x1(t) ≥ S̄ − ζ1 − ζ2, and V (t) ≥ x2(t) ≥ V̄ − ζ1 − ζ2 for t ≥ t2.
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From the infected components of system (2.16), we have
dC
dt




= σC − g3I
dR
dt
= γCC + γII − g4R

t 6= nT, n ∈ N (2.23)
where g2 = (π + σ + γC), g3 = (π + γI + δ), g4 = (π + κ). Consider the auxiliary system
u′(t) = (F − V )u(t), t 6= nT, n ∈ N (2.24)
where u = (u1, u2)
T . The solution of system (2.24) can be expressed as
u(t, nT, u(nT+)) = Φ(F−V )(t − nT )u(nT+). Then u((n + 1)T+) = P2Φ(F−V )(T )u(nT+).
WhileRp = ρ(P2Φ(F−V )(T )) > 1, u1 →∞ and u2 →∞ as t→∞. Then limt→∞C =∞ and
limt→∞ I =∞, which contradicts with the boundedness of (C, I). Thus the claim is proved;
that is, lim supt→∞C(t) ≥ L and lim supt→∞ I(t) ≥ L, which implies lim supt→∞R(t) ≥ L.
From the claim, we discuss the following two possibilities.
(I) C(t) ≥ L and I(t) ≥ L for all large t;
(II) C(t) and I(t) oscillates about L for all large t.
If condition (I) holds, then the proof is complete. Next we consider the possibility of condition
(II). Since lim supt→∞C(t) ≥ L and lim supt→∞ I(t) ≥ L, there exists a t1 ∈ (n1T, (n1 + 1)T ]
and t2 ∈ (n2T, (n2 + 1)T ] such that C(t1) ≥ L, I(t1) ≥ L and C(t2) ≥ L, I(t2) ≥ L, where
n2−n1 ≥ 0 is finite. Then we will consider the solution of the following equation from system





= β(ηC + I)[S̄ + (1− ε)V̄ ]− k3C + δCI ≥ −k3C
dI
dt
= σC − k4I + δI2 ≥ −k4I.
Integrating the above equation from t1 to t, we have
C(t) ≥ C(t1)e−g2(t−t1) ≥ Le−g2(t2−t1) ≥ Le−g2(n2−n1+1)T
I(t) ≥ I(t1)e−g3(t−t1) ≥ Le−g3(t2−t1) ≥ Le−g3(n2−n1+1)T
Let L1 = min{Le−g2(n2−n1)T ), Le−g3(n2−n1)T ), }, then L1 > 0 cannot be infinitely small since
n2 − n1 ≥ 0 is finite. We have C(t) ≥ L1 > 0 and I(t) ≥ L1 > 0.
For t > t2, the same arguments can be continued. We similarly get non-infinitesimal positive
L2. Therefore, we can get the sequence {Lk} where
Lk = min{Le−g2(nk+1−nk)T , Le−g3(nk+1−nk)T}, k = 1, 2 · · · j · · · .
is non-infinitesimal since nk+1 − nk ≥ 0 is finite. Thus, solution of system (2.16) satisfies
C(t) ≥ Lk > 0 and I(t) ≥ Lk > 0 holds true in the time interval [tk, tk+1], where tk ∈
(nkT, (nk + 1)T ], and tk+1 ∈ (nk+1T, (nk+1 + 1)T ]. Let L∗ = mink{Lk} = Ll > 0, l ∈
N, Ll ∈ {Lk}, k = 1, 2, · · · . Thus, from the above discuss, we have that C(t) ≥ L∗ > 0 and
I(t) ≥ L∗ > 0 for all t ≥ t1. Hence, the proof is complete.
2.5 Numerical simulation of the impulsive model
In this section, we present the numerical results of the impulsive model using 85% vaccine
efficacy along with the parameter values in Table 2.2. In order to assess the impact of
impulsive vaccination on the population, we implemented 15 vaccination pulses periodically
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for a month with vaccination rate ν = 0.48681. We observed from Figure 2.6 the number
of vaccinated individuals increasing with increasing pulses which leads to a decrease in the
number of infected and increase in the recovered individuals. We see similar dynamics when
a lower vaccination rate, ν = 0.14868, is used; in this case susceptible and vaccinated are
S(t) = 630 and V (t) = 1173 at 10 days (see Figure 2.6(a)). However, when a higher
vaccination rate was used, susceptible and vaccination at 10 days are S(t) = 120 and V (t) =
2140 respectively. This result is in line with the result obtained from the sensitivity analysis
in Section 2.3.4. Thus, higher vaccination rate protect more people in the community than
a lower vaccination rate.


















































Figure 2.6: Numerical simulation of the sub-population using (a) A low vaccination rate ν ≈ 0.1;
(b) A higher vaccination rate ν ≈ 0.5. Other parameter values used are as given in Table 2.2.
Furthermore, in Figure 2.7 we observed in absence of vaccination more susceptible individuals
at the final time who can be infected with the disease compared to when there is vaccina-
tion (see Figures 2.7(a) and 2.7(b)). Similar, results holds at the final time for the carrier
and infected individuals in the absence of vaccination compared to when the population is
vaccinated.
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Figure 2.7: Bar plot for the final size of each sub-population. (a) Final size of the population
without vaccination; (b) Final size of the population with 85% vaccination coverage. Parameter
values used are as given in Table 2.2.
Next, we explore the impact of different vaccination pulses on disease burden in the com-
munity on the final size at the final time of 30 days. We observed from Figures 2.8(a) and
2.8(b) with low and high vaccination rate that as the number of pulses increase, the vacci-
nated population increases leading to a decrease in the infected individuals in the community.
It should be noted that as we increase the number of vaccine pulses within a month, the
pulse period reduces. That is, our pulse vaccine period decreases from 5 days to 2 days, and
the number of pulses increase from 6 pulses to 15 pulses as the days decreases.
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Figure 2.8: Numerical simulation of the sub-population final size. (a) A low vaccination rate
ν ≈ 0.1; (b) A higher vaccination rate ν ≈ 0.5. Parameter values used are as given in Table 2.2.
2.6 Discussion and conclusions
2.6.1 Discussion
Neisseria meningitis is a bacteria responsible for causing meningococcal meningitis with a
potential of causing epidemics mostly from six of the twelve different serotypes, namely the
serotypes A, B, C, W, X and Y (Rouphael & Stephens, 2012; World Health Organization
(WHO), 2018). In 2017, an outbreak of meningitis C occurred in Nigeria with over 9,902
cases and 602 deaths in 31 states of the country (Nigeria Centre for Disease Control (NCDC),
2017). The outbreak was exacerbated by the shortage of vaccine (British Broascasting Co-
operation (BBC), 2017; News24, 2017; Nigeria Centre for Disease Control, 2017; Voice of
America (VOA), 2017). This is due to the fact that the meningitis C polysaccharide vac-
cines are currently being phased out in other parts of the world (World Health Organization
(WHO), 2017). Unfortunately, the more effective and long-lasting conjugate vaccines are
not readily and promptly available (World Health Organization (WHO), 2017).
In this study, we developed two types of mathematical models, ordinary differential equation
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model (which we will call non-impulsive model (2.6)) and impulsive differential equation
model (which we will refer to as impulsive model (2.16)) respectively. Theoretical analysis
of the two models showed that the disease free equilibrium of non-impulsive model is locally
asymptotically stable if the reproduction number, R0, is less than one. While the disease
free periodic solution of the impulsive model is locally asymptotically stable if the threshold
quantity Rp is less than one. The biological implication of these results is that we will be
able to control the disease in the community whenever these quantities (R0 and Rp) are less
that one. Note that Rp is not the reproduction number of the impulsive system, it is just a
threshold that guarantees the stability of the equilibrium solutions.
Next, we carried out sensitivity analysis of the non-impulsive model (2.6) using the basic
reproduction number as the response function. The results shown with the bar plot of
the sensitivity indices in Figure 2.3 reveals that the transmission probability (β), disease
modification parameter (η), recovery rate of carrier (γC) and vaccine efficacy (ε) are the
parameters with most influence on the basic reproduction number. The implication of these
results is that whenever we increase the transmission probability (β) by 10% there will be a
corresponding 10% increase in disease burden since the sensitivity index is 1.00. Similarly,
a 10% increase in recovery rate among the carrier population (γC) and vaccine efficacy (ε)
will lead respectively to a 6.2% and 14% decrease in disease burden since their respective
sensitivity indices are −0.619 and −1.388.
We then assess the impact of vaccine efficacy and its coverage in eradicating the disease in
the population using the non-impulsive model (2.6) since we can easily assess the impact
of vaccine efficacy (ε) unlike the transmission probability (β) and the recovery rate of the
carrier population, γC . Agusto & Leite (2019) investigated the effect of controlling meningitis
in Nigeria using optimal control with two time-dependent controls on vaccination and facial
masks. The use of facial masks act to reduce the transmission probability (β). We observed
from the bar plot showing the effect of vaccine efficacy and vaccine coverage using the
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reproduction number in Figures 2.4 and 2.5 that meningitis can effectively be controlled
in the population using an imperfect vaccine with an efficacy above 75% and high vaccine
coverage rate of at least 85%.
Vaccine is a highly effective control strategy against the disease, and “can drastically reduce
the magnitude of the epidemic” (World Health Organization (WHO), 2017). Individuals
in the meningitis belt have mostly been protected against meningitis A by the use of Men
A conjugate vaccine (MACV) which was introduced in 2010 (World Health Organization
(WHO), 2017). Nineteen countries have administered the vaccine with over 260 million
people been vaccinated leading to over 57% reduction in meningitis cases. Unfortunately,
this is not the case with Men C (United Nations Children’s Fund (UNICEF), 2017; World
Health Organization (WHO), 2017) as observed in the 2017 meningitis C outbreak in Nigeria,
most of the population are not protected against this serogroup. In a future study we will
investigate the effect of vaccination in the strain replacement of meningitis A by meningitis
C in Nigeria.
Hence, to ensure the protection of the population, particularly people living in hard-to-
reach areas of the region, we propose the use of pulse vaccination which is an effective
way of controlling disease transmission with some practical advantages (Agur et al., 1993;
d’Onofrio, 2005; Gao & Chen, 2005; Shulgin et al., 1998; Stone et al., 2000; Zou et al., 2009).
It is sometimes more effective than constant vaccination (Li & Yang, 2011; Li & Cui, 2009;
Röst & Vizi, 2014; Shulgin et al., 1998). In a different study we will access the impact of
using an optimal vs impulse control in curtailing the transmission of the disease.
In this study, we use the impulsive model (2.16) to assess the impact of vaccinating the
populace. Our results shows that vaccinating with a lower rate slowly protects and prevent
the disease transmission unlike when a high vaccination rate is used (see Figure 2.6) more
people are protected at a faster rate. Furthermore, we observed in Figure 2.7 that vaccina-
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tion, regardless of the rate, offers protection against the disease. We observed further that
as we increase the vaccination pulses over a 30 days period (see Figure 2.8) more and more
people in the population are protected. We expect that this vaccination strategy will help
increase the herd immunity of the community particularly those in hard-to-reach places of
the country where the disease is endemic.
2.6.2 Conclusions
In this study, we developed two mathematical models, an ordinary differential equation model
with constant vaccination and an impulsive differential equation model with impulsive vacci-
nation. The main results obtained from the theoretical analysis of two mathematical models,
non-impulsive model (2.6) and impulsive model (2.16) developed in this study, the results
obtained from the determination of a minimum vaccine efficacy and coverage needed for ef-
fective control of meningitis, and the results from the numerical exploration are summarized
below.
(i) The non-impulsive meningitis model has a locally asymptotically stable disease free
equilibrium whenever R0 < 1 and unstable if R0 > 1;
(ii) Sensitivity analysis reveals transmission probability β, recovery rate of carrier γC and
vaccine efficacy ε as the important parameter impacting the reproduction number;
(iii) Meningitis can be effectively controlled in the population using an imperfect vaccine
with an efficacy > 75% and high vaccine coverage rate of at least 85%;
(iv) The impulsive model is locally asymptotically stable if the threshold Rp < 1;
(v) Numerical simulations of the impulsive model shows that meningitis can be curtailed
by the use of impulsive vaccine in the population.
(vi) Infection decreases with the number of vaccination pulses.
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Chapter 3
Modeling Co-infection of Meningitis A and C
3.1 Introduction
In the previous chapter, we focused on the control of meningitis in the population, by ac-
cessing the effect of vaccination in eradicating the disease. This entails the use of both
constant and impulsive vaccination schemes. However, since meningitis is a disease with
multiple strains, it should be noted that geographical distribution and epidemic potential of
this disease differs according to each serogroup. For example, as mentioned by Peterson et al.
(2019), Neisseria meningitis W (NmW) was the predominant serogroup in most of Africa
except Algeria, Cameroon, Chad, Guinea and Nigeria. In addition, Neisseria meningitis A
(NmA) was reported as the most prevalent in Cameroon, Chad and Guinea, while Neisseria
meningitis C (NmC) is the most prevalent serogroup in Nigeria. In the Americas, Neisseria
meningitis B (NmB) was reported as the most prevalent serogroup, while the second most
prevalent serogroup is Neisseria meningitis Y (NmY) within North America. Peterson et al.
(2019) stated NmB as the predominated serogroup within Europe. In their study, India was
the only country where reported cases were identified as NmA.
In the African meningitis belt, serogroup A was responsible for the large majority of epi-
demics prior to 2010. However, the progressive introduction of a meningococcal A conjugate
vaccine (MenAfriVac) to the epidemic prone areas in the African meningitis belt has brought
about a dramatic reduction in cases of this serogroup and the elimination of its epidemics
in these areas. On the other hand, the relative proportion of cases due to other serogroups
(W, X and C) and Streptococcus pneumoniae has increased, thus replacing the dominant
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strain A in the population (World Health Organization (WHO), 2019a). For instance, be-
tween January 1996 to June 1996 a severe meningitis serogroup A outbreak occurred in
Nigeria with 109,580 cases and 11,717 deaths, with a 10.69% fatality rate (World Health
Organization (WHO), 2017). Since 2010, Nigeria has been carrying out mass immunization
campaigns with MenAfriVac against the meningitis A serogroup. This has led to a decline
in the incidence of meningitis A serogroup in this region. However, since 2013 Nigeria has
been experiencing large outbreaks of a hyper-invasive strain of meningococcal meningitis
serogroup C. In 2015, over 2500 cases of the disease were reported in the country (World
Health Organization (WHO), 2017). Another outbreak occurred in 2017 in Nigeria with over
9,902 cases and 602 deaths in thirty-one states of the country (Nigeria Centre for Disease
Control (NCDC), 2017).
In this section, we formulate a deterministic model with multiple strains of meningococcal
meningitis (serogroup A and serogroup C), to study the dynamical behavior of meningitis
A and meningitis C in the presence of vaccination under different scenarios. The scenarios
considered in this thesis include the more generalized model with co-infected individuals of
strain A and C, and also the model with the absence of individuals co-infected with the
two strains. In addition, since there is no data on the ability of individuals to be infected
with the two strain at the same time, we consider the case where we assume that co-infected
individuals can only transmit the strain with the highest transmission probability (due to
within-host competitive advantage).
3.2 Formulation of the model
3.2.1 Formulation of the full meningitis model with co-infection
The model sub-divides the total human population at time t, denoted by N(t), into sus-
ceptible individuals (S), vaccinated individuals (V ), carrier individuals with strain A (CA),
infected individuals with strain A (IA), recovered individuals from strain A (RA), carrier
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individuals with strain C (CC), infected individuals with strain C (IC), recovered individuals
from strain C (Rc), carrier individuals with both strain A and C (CAC), infected individuals
with both strain A and C (IAC), and recovered individuals from both strain A and C (RAC).
Thus, the total human population is given by
N(t) = S + V + CA + IA +RA + CC + IC +RC + CAC + IAC +RAC
Flow from one class to the other is as a result of interaction with respect to the disease.
The population of susceptible humans is generated by the recruitment rate which is by birth
or immigration at rate π, immunity loss of vaccinated individuals ω and by vaccine waning
of strain A, C and AC individuals at rate κA, κC and κAC respectively. The susceptible
population is reduced by natural death at rate µ and by vaccination, at rate ν. In addi-
tion, considering that susceptible individuals can be infected by contact with strain A, or
strain C carrier or infected individuals, we further consider the scenario with super-infection,
where susceptibles are becoming infected through contact with the co-infected individuals.
However, such individual will progress to the strain population that has the within-host
competitive advantage in co-infected individuals. The susceptible population is depopulated
by the infection function of the susceptible by strain A, strain C, and by strain AC carrier













The parameters βA, and βC , are transmission probabilities per contact for strain A, and
strain C respectively. βAC indicates that strain A is stronger in transmission in co-infected
individuals while βCA indicates that strain C is stronger in transmission in co-infected indi-
viduals. Thus, λAC is the force of infection which indicates when strain A have within-host
advantage of over strain C, while λCA is the force of infection which indicates when strain C
have within-host advantage of over strain A. Furthermore, the modification parameter η < 1
48
accounts for the assumed increase in the relative infectiousness of infected individuals in the
IA, IC and IAC classes compared to those in the corresponding carrier classes CA, CC and
CAC . In other words, the model employs the fact that carrier individuals can transmit in-
fection, the rate at which this occurs is smaller than the rate at which infectious individuals
transmit infection (since, in general, infectiousness is positively correlated with viral load).
Hence, the susceptible population at any time t is given as
dS
dt
= π + ωV + κARA + κCRC + κACRAC − (λA + λC + λAC + λCA)S − (ν + µ)S
The vaccinated population is obtained as a result of vaccination on the susceptible class at
a rate ν. However, owing to imperfect vaccine, the vaccinated population is reduced due
to breakthrough infection via contact with carrier or infected individual (at a reduced rate
of fraction (1 − ε), where 0 < ε < 1 is the vaccine efficacy). The vaccinated population
is further depopulated via natural death at rate µ, and waning vaccine at rate ω. The
vaccinated population is then given as follows
dV
dt
= νS − (1− ε)(λA + λC + λAC + λCA)V − (ω + µ)V
Strain A carrier individuals derive from infection occuring in both the susceptible and vac-
cinated populations. This group is decreased by the force of infection for strain C at the
rate θCλC , disease progression to strain A infected population at rate σA, and natural death
at rate µ. The modification parameter 0 ≤ θC ≤ 1 accounts for the assumed reduction of
susceptibility to strain C of individuals who are already infected with strain A. Thus, the
strain A carrier population is given below as
dCA
dt
= (λA + λAC)S + (1− ε)(λA + λAC)V − θCλCCA − (σA + µ)CA
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The strain A infected population is generated following the progression from the strain A
carrier population. This population is reduced by the individual contact with strain C carrier
or infected individuals θCλC , recovery at rate γA, natural death µ and death resulting from
complication of infection with strain A at rate δA. θCλC accounts for the assumed reduction
of susceptibility to strain C of individuals who are already infected with strain A. The strain
A infected population is given as
dIA
dt
= σACA − θCλCIA − (γA + µ+ δA)IA
The strain A recovered individuals increase in number as a result of recoveries from strain A
infected population at rate γA. Depopulation of this population results from loss of immunity
at rate κA and natural death at rate µ. The strain A recovered population is then given as
dRA
dt
= γAIA − (κA + µ)RA
Strain C carrier individuals are derived infection coming of both susceptible and vaccinated
population. This is further depopulated by the force of infection for strain A at the rate
θAλA, disease progression to strain C infected population at rate σC and natural death
at rate µ.The modification parameter 0 ≤ θA ≤ 1 accounts for the assumed reduction of
susceptibility to strain A of individuals who is already infected with strain C. Thus, strain
C carrier population is given below as
dCC
dt
= (λC + λCA)S + (1− ε)(λC + λCA)V − θAλACC − (σC + µ)CC
The strain C infected population is generated following by progression from the strain C
carrier population. This population is reduced by the individual contact with strain A
carrier or infected individuals θAλA, recovery at rate γC , natural death µ and death resulting
from complication of infection with strain C at rate δC . θAλA accounts for the assumed
50
reduction of susceptibility to strain A of individuals who are already infected with strain C.
The strain C infected population is given as
dIC
dt
= σCCC − θAλAIC − (γC + µ+ δC)IC
The strain C recovered individuals increase in number as a result of recoveries from the
strain C infected population at rate γC . Depopulation of this population results from loss




= γCIC − (κC + µ)RC
The coinfected strain A and C carrier individuals derive from infection in both strain A
carrier and infected populations and in strain C carrier and infected populations. This is
further depopulated by disease progression to coinfected strain AC infected population at
rate σAC . Furthermore, the population is depopulated by natural death at rate µ. The
coinfected strain AC carrier population is given below as
dCAC
dt
= θAλACC + θCλCCA − (σAC + µ)CAC
The coinfected strain A and C infected population derive from infection coming of both
strain A infected and strain C infected population, and from progression from the coinfected
strain AC carrier population. This population is reduced by recovery at rate γAC , natural
death µ and death resulting from complication of infection with strain AC at rate δAC . The
coinfected strain AC infected population is then given as
dIAC
dt
= σACCAC + θAλAIC + θCλCIA − (γAC + µ+ δAC)IAC
The coinfected Strain A and C recovered individuals increase in number as a result of recov-
eries from the strain AC infected population at rate γIAC . Depopulation of this population
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result from loss of immunity at rate κAC and natural death at rate µ. The coinfected strain
AC recovered population is given as
dRAC
dt
= γACIAC − (κAC + µ)RAC
Hence, the overall process explained above leads to the model for the transmission dynam-




= π + ωV + κARA + κCRC + κACRAC − (λA + λC + λAC + λCA)S − (ν + µ)S
dV
dt
= νS − (1− ε)(λA + λC + λAC + λCA)V − (ω + µ)V
dCA
dt
= (λA + λAC)S + (1− ε)(λA + λAC)V − θCλCCA − (σA + µ)CA
dIA
dt
= σACA − θCλCIA − (γA + µ+ δA)IA
dRA
dt
= γAIA − (κA + µ)RA (3.1)
dCC
dt
= (λC + λCA)S + (1− ε)(λC + λCA)V − θAλACC − (σC + µ)CC
dIC
dt
= σCCC − θAλAIC − (γC + µ+ δC)IC
dRC
dt
= γCIC − (κC + µ)RC
dCAC
dt
= θAλACC + θCλCCA − (σAC + µ)CAC
dIAC
dt
= σACCAC + θAλAIC + θCλCIA − (γAC + µ+ δAC)IAC
dRAC
dt
= γACIAC − (κAC + µ)RAC
A schematic flow diagram of the model (3.1) is depicted in Figure 3.1, and the associated





CA, CC , CAC Carrier individuals with strain A, C, A and C
IA, IC , IAC Infected individuals with strain A, C, A and C





ω Vaccine waning rate
βi Transmission probability
η, θA, θC Disease modification parameter
µ Natural death rate
γA, γC , γAC Recovery rate of infected individuals with strain A, C, A and C
σA, σC , σAC Progression rate of carrier individuals with strain A, C, A and C to infected
κA, κC , κAC Immunity waning rate of recovered individuals from strain A, C, A and C
δA, δc, δAc Disease induced death rate
Table 3.1: Description of the variables and parameters of the full meningitis model (3.1).
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Figure 3.1: Schematic illustration of the full co-infection meningitis model (3.1).
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3.2.2 Formulation of the sub-model without co-infection
In this section, we present a sub-model which assumed the absence of co-infected individuals
with the two strains in the population. Hence, by setting the variables and parameters of
the co-infected individuals to zero, the system of equation for the full model (3.1) reduces
to the following system of equations:
dS
dt
= π + ωV + κARA + κCRC − (λA + λC)S − (ν + µ)S
dV
dt
= νS − (1− ε)(λA + λC)V − (ω + µ)V
dCA
dt
= λAS + (1− ε)λAV − (σA + µ)CA
dIA
dt
= σACA − (γA + µ+ δA)IA
dRA
dt
= γAIA − (κA + µ)RA (3.2)
dCC
dt
= λCS + (1− ε)λCV − (σC + µ)CC
dIC
dt
= σCCC − (γC + µ+ δC)IC
dRC
dt
= γCIC − (κC + µ)RC















































Figure 3.2: Schematic illustration of the meningitis sub-model without co-infection. The full model
is reduced to (3.2) when there are no individuals that are infected with both strains of the disease.
3.3 Analysis of the full meningitis model with co-infection
3.3.1 Basic qualitative properties of the full model
In this section, the basic qualitative properties of the model (3.1) will be explored.
Positivity and Boundedness of Solutions
For the meningitis model (3.1) to be epidemiologically meaningful, it is important to prove
that all its state variables are non-negative for all time t ≥ 0. In other words, solutions of
the model system (3.1) with non-negative initial data will remain non-negative for all time
t > 0.
Lemma 3 Let the initial data S(0) > 0, V (0) ≥ 0, CA(0) ≥ 0, IA(0) ≥ 0, RA(0) ≥ 0,
CC(0) ≥ 0, IC(0) ≥ 0, RC(0) ≥ 0, CAC(0) ≥ 0, IAC(0) ≥ 0, and RAC(0) ≥ 0. Then, the solu-
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tions (S(t), V (t), CA(t), IA(t), RA(t), CC(t), IC(t), RC(t), CAC(t), IAC(t), RAC(t)) of the menin-






Proof. Let t1 = sup{t > 0 : S(t) > 0, V (t) > 0, CA(t) > 0, IA(t) > 0, RA(t) > 0, CC(t) >
0, IC(t) > 0, RC(t) > 0, CAC(t) > 0, IAC(t) > 0, RAC(t) > 0 ∈ [0, t]}. Thus, t1 > 0. It follows
from the first equation of the system (3.1), that
dS
dt
= π + ωV + κARA + κCRC + κACRAC − (λA + λC + λAC + λCA + ν + µ)S




+ (λA + λC + λAC + λCA + νA + µ)S ≥ 0
Multiplying by Integrating factor I.F, exp
{∫ t1
0










[λA(ψ) + λC(ψ) + λAC(ψ) + λCA(ψ)] dψ + (ν + µ)t
}]
≥ 0 (3.3)




[λA(ψ) + λC(ψ) + λAC(ψ) + λCA(ψ)] dψ + (ν + µ)t
}
≥ C










It can similarly be shown that V (t) > 0, CA(t) > 0, IA(t) > 0, RA(t) > 0, CC(t) > 0, IC(t) >
0, RC(t) > 0, CAC(t) > 0, IAC(t) > 0, RAC(t) > 0 for all t > 0.
Invariant region
Consider the biological feasible region




Lemma 4 The region D defined by (3.4) is positively-invariant and attracting for model
(3.1) with non-negative initial conditions in R11+ .
Proof. Let [S(t), V (t), CA(t), IA(t), RA(t), CC(t), IC(t), RC(t), CAC(t), IAC(t), RAC(t)] ∈ R11+ ,
be the solution of model (3.1) with non-negative initial conditions. The rate of change of
the total population is obtained by adding up the compartments of the system (3.1) to give
dN
dt
= π − µN − δAIA − δcIC − δACIAC ≤ π − µN (3.5)
Since, dN
dt
≤ π − µN , it follows that dN
dt





+ µN = π (3.6)
Using the integrating factor method, so that equation (3.6) can be written as
d(Neµt) = πeµtdt



























In particular, N(t) ≤ π
µ
, if N(0) ≤ π
µ
. Thus, every solution of the model (3.1) with initial
conditions in D remains there for t > 0. Thus, D is a positive-invariant. Hence, it is sufficient
to consider the dynamics of the flow generated by (3.1) in D. In this region, the model is
said to be mathematically and epidemiologically well posed (Hethcote, 2000). Thus, every
solution of the meningitis model (3.1) with initial conditions in D remains in D for all t > 0.
3.3.2 Stability of the disease free equilibrium (DFE)
The meningitis model (3.1) has a disease free equilibrium obtained by setting the right-hand
sides of the equations in the model to zero and solving at CA = CC = CAC = IA = IC =
IAC = 0. Thus, the disease free equilibrium is given by




µ(ν + µ+ ω)
,
πν
µ(ν + µ+ ω)
, 0, 0, 0, 0, 0, 0, 0, 0, 0
)
(3.7)
The linear stability of E0 can be established using the next generation operator method.
Using the infected compartment, matrices F and V , for the transmission matrix (new infec-
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0 0 0 0 0 0






k3 0 0 0 0 0
−σA k4 0 0 0 0
0 0 k6 0 0 0
0 0 −σC k7 0 0
0 0 0 0 k9 0
0 0 0 0 −σAC k10

(3.9)
Where k3 = σA + µ, k4 = γA + µ + δA, k6 = σC + µ, k7 = γC + µ + δC , k9 = σAC + µ,
k10 = γAC + µ + δAC and P = S
∗ + (1 − ε)V ∗. It follows that the reproduction number of
the meningitis model (3.1) is given by












where ρ is the spectral radius (highest eigenvalue) of the matrix FV −1 and N∗ = S∗ + V ∗.
The above threshold quantity (basic reproduction number) is defined as
R0 = max {R0A, R0C}
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∗ + (1− ε)V ∗]
k6k7N∗
(3.11)
Theorem 4 The meningitis model (3.1) disease-free equilibrium E0 is locally-asymptotically
stable (LAS) if R0 < 1 and unstable if R0 > 1.
The basic reproduction number R0 measures the average number of new infections generated
by a single infected person during his or her infectious period in a population that is fully
susceptible. Thus, the epidemiological implication of Theorem 4 above is that meningitis
will be controlled in the population whenever R0 < 1 if the initial sizes of the population of
the model are in the basin of attraction of the DFE (E0).
3.3.3 Existence and Stability of Boundary Equilibria
Here, we will explore the possible equilibria of the model. There are two possible single-
strain infection equilibria E1 = (S∗∗, V ∗∗, C∗∗A , I∗∗A , R∗∗A ) and E2 = (S∗∗, V ∗∗, C∗∗C , I∗∗C , R∗∗C ) for
existence of strain A and C respectively. Also, the model (3.1) has a double strain infection
equilibrium E3 = (S∗∗, V ∗∗, C∗∗A , I∗∗A , R∗∗A , C∗∗C , I∗∗C , R∗∗C , C∗∗AC , I∗∗AC , R∗∗AC).
Strain A-only Boundary Equilibrium (E1)
Here we will establish the conditions for the existence of an equilibrium for which strain
A-only is endemic in the population. The meningitis model (3.1) with strain A-only in the
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absence of strain C reduces to the system of equations below,
dS
dt
= π + ωV + κARA − λAS − k1S
dV
dt
= νS − pλAV − k2V
dCA
dt
= λAS + pλAV − k3CA (3.12)
dIA
dt
= σACA − k4IA
dRA
dt
= γAIA − k5RA
where k1 = ν + µ, k2 = ω + µ, k3 = σA + µ, k4 = γA + µ + δA, k5 = κA + µ, p = 1 − ε.
The infection equilibrium of the strain A-only system (3.12) in terms of the force of infection
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A + k2 + pν)
k3k4k5(λ∗∗A + k1)(pλ
∗∗
A + k2)− k3k4k5ων − λ∗∗A κAγA(pλ∗∗A + k2 + pν)










The total population is obtained by summing up the sub-populations as below








A + k2 + ν) + (λ
∗∗
A πk4k5 + λ
∗∗




A + k2 + pν)
k3k4k5(λ∗∗A + k1)(pλ
∗∗
A + k2)− k3k4k5ων − λ∗∗A κAγA(pλ∗∗A + k2 + pν)
(3.15)
Substituting equation (3.13) amd (3.15) into (3.14) gives,
λ∗∗A =
λ∗∗A βA(ηπk4k5 + πσAk5)(pλ
∗∗
A + k2 + pν)
πk3k4k5(pλ∗∗A + k2 + ν) + (λ
∗∗
A πk4k5 + λ
∗∗




A + k2 + pν)
(3.16)
Further simplification of (3.16) shows that the positive equilibria of the model (3.12) satisfy





A + c0 = 0 (3.17)
where
a0 = πk4k5p+ πk5σAp+ πγAσAp
b0 = πk2k4k5 + πk3k4k5p+ πk4k5pν + πk2k5σA + πk5σApν + πγAσAk2
−βAηπk4k5p− βAπk5σAp (3.18)
c0 = πk2k3k4k5 + πk3k4k5ν − βAηπk2k4k5 − βAηπk4k5pν − βAπk2k5σA − βAπk5σApν
In order to write the expression of c0 in form of R0A, we set c0 > 0, then
πk2k3k4k5 + πk3k4k5ν > βAηπk2k4k5 + βAηπk4k5pν + βAπk2k5σA + βAπk5σApν
k2k3k4k5 + k3k4k5ν > βAηk2k4k5 + βAηk4k5pν + βAk2k5σA + βAk5σApν
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Substituting k2 = ω + µ results to,
k3k4(ω + µ+ ν) > βA(ηk4 + σA)(ω + µ+ pν) (3.19)
So that
R0A =
βA(ω + µ+ pν)(ηk4 + σA)
k3k4(ν + ω + µ)
< 1
Hence,
c0 ≡ k3k4(ν + ω + µ)(1−R0A)
Thus, the positive endemic equilibria of the meningitis strain A-only model are obtained by
solving the quadratic equation (3.17) and substituting the results (positive values of λ∗∗A )







where a0, b0, c0 are defined as in equation (3.18) above.
The quadratic equation (3.17) above can be analyzed for the possibility of multiple endemic
equilibria whenever R0A < 1. It should be noted that the coefficient a0 of the quadratic
equation (3.17) is always positive; and the constant term c0 is negative (positive) whenever
R0A is greater (less) than unity. Hence, the following result is established.
Theorem 5 The meningitis strain A-only model (3.12) has:
(i) a unique endemic equilibrium if c0 < 0 ⇐⇒ R0A > 1;
(ii) a unique endemic equilibrium if (b0 < 0 and c0 = 0) or b
2
0 − 4a0c0 = 0;
(iii) two endemic equilibria if c0 > 0, b0 < 0 and b
2
0 − 4a0c0 > 0;
(iv) no endemic equilibrium otherwise.
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Thus, it is clear from case (i) of Theorem 5 that the meningitis strain A-only model (3.12)
has a unique EEP (of the form E1) whenever R0A > 1. Furthermore, case (iii) of Theorem
5 indicates the possibility of backward bifurcation, where a LAS DFE co-exists with a LAS
endemic equilibrium when the associated reproduction number R0A is less than unity (R0A <
1). To check for the possibility of backward bifurcation in the meningitis strain A-only model
(3.12), the discriminant b20− 4a0c0 of quadratic (3.17), is set to zero and the result solved for
the critical value of R0A (denoted by R0A∗ < 1). This gives;
R0A∗ = 1−
b20
4a0k3k4(ν + ω + µ)
(3.21)
for which it can be shown that backward bifurcation occurs for values of R0A∗ such that
R0A∗ < R0A < 1. The epidemiological importance of the phenomenon of backward bifurca-
tion is that, the requirement of having R0A < 1 is necessary, but not sufficient for disease
elimination.
Bifurcation analysis for meningitis strain A-only model
Following the above results, we will explore the possibility of backward bifurcation for the
Meningitis strain A-only model. The phenomenon of backward bifurcation which has been
observed in numerous disease transmission dynamics is totally characterized by the co-
existence of a stable disease-free equilibrium and a stable endemic equilibrium when the
associated reproduction number is less than unity. Here, we will employ the Centre Mani-
fold theory (Carr, 1981), as described by Castillo-Chavez & Song (2004) to investigate the
existence of backward bifurcation. We claim the following result (the proof is given in Ap-
pendix B.1)
Theorem 6 The meningitis strain A-only model (3.12) undergoes a backward bifurcation at
R0A = 1 whenever the coefficient “a”, given in Appendix B.1 equation (B.5) is positive.
The proof of Theorem 6 is given in Appendix B.1. Using the baseline parameter values
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(except for βA = 0.6690, ω = 0.100), the bifucation paramters “a” and “b” given in Appendix
B.1 are obtained as a = 0.024353 > 0 and b = 183.500426 > 0 respectively. The implication
of backward bifurcation phenomenon is that the classical epidemiology requirement of having
the reproduction number less than unity, while necessary, is no longer sufficient for the
effective control of the disease in the population. Hence, the effective control of meningitis
strain A in the population is difficult, since disease control when R0A < 1 is dependent on
the initial sizes of the sub-populations of the model (3.12).
Global stability of meningitis strain A-only for special case ε = 0
Theorem 7 The disease free equilibrium, Ê1 of the meningitis strain A-only sub-model
(3.12), for special case ε = 0 is globally asymptotically stable whenever R0A ≤ 1. The
disease free equilibrium, Ê1 =
(
π(ω + µ)
µ(ν + µ+ ω)
,
πν
µ(ν + µ+ ω)
, 0, 0, 0
)
Proof: Consider the following Lyapunov function
L = b1CA + b2IA
with Lyapunov derivate (where dots represents differentiation with respect to time t).
L̇ = b1ĊA + b2İA
= b1(λAS + λAV − k3CA) + b2(σACA − k4IA) (3.22)




In order to obtain the value of b1 and b2 respectively, a small perturbation of equation (3.23)
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with the reproduction number of meningitis strain A-only gives b1 = (ηk4 +σA) and b2 = k3.
Substituting back the value of b1 and b2 above into equation (3.23) yields:
L̇ = (ηk4 + σA)λAS − CA[(ηk4 + σA)k3 − k3σA]− IAk3k4
= (ηk4 + σA)βA(ηCA + IA)
S
N
− k3k4(ηCA + IA)
Since S ≤ N in the domain D
L̇ ≤ (ηk4 + σA)βA(ηCA + IA)− k3k4(ηCA + IA)
≤ (ηCA + IA) [βA(ηk4 + σA)− k3k4]






= k3k4(ηCA + IA)(R0A − 1) ≤ 0. (3.24)
Since all model parameters are non-negative, it follows that L̇ ≤ 0 for R0A ≤ 1 with L̇ = 0
if and only if CA = IA = 0. Thus, by LaSalle’s Invariance Theorem, every solution to the
equation of the model (3.12), with initial conditions in the domain D, approaches D0 as
t −→∞, whenever R0A ≤ 1.
Strain C-only boundary equilibrium (E2)
Here we will establish the conditions for the existence of an equilibrium for which strain
C-only is endemic in the population. The meningitis model (3.1) with strain C-only in the




= π + ωV + κCRC − λCS − k1S
dV
dt
= νS − pλCV − k2V
dCC
dt
= λCS + pλCV − k6CC (3.25)
dIC
dt
= σCCC − k7IC
dRC
dt
= γCIC − k8RC
where: k1 = ν + µ, k2 = ω + µ, k6 = σC + µ, k7 = γC + µ+ δC , k8 = κC + µ, p = 1− ε.
Let E2 = (S∗∗, V ∗∗, C∗∗C , I∗∗C , R∗∗C ) be the infection equilibrium of the meningitis model with
strain C-only system (3.25). The expression of the equilibrium E2 is given in Appendix B.2.
For the strain C-only system (3.25), we present the following results
Theorem 8 The meningitis strain C-only model (3.25) has:
(i) a unique endemic equilibrium if c1 < 0 ⇐⇒ R0C > 1;
(ii) a unique endemic equilibrium if (b1 < 0 and c1 = 0) or b
2
1 − 4a1c1 = 0;
(iii) two endemic equilibrium if c1 > 0, b1 < 0 and b
2
1 − 4a1c1 > 0;
(iv) no endemic equilibrium otherwise.
The proof of Theorem 8 is given in Appendix B.2. Thus, it is clear from case (i) of Theorem
8 that the meningitis strain C-only model (3.25) has a unique EEP (of the form E2) whenever
R0C > 1. Furthermore, case (iii) of Theorem 8 indicates the possibility of backward bifur-
cation, where a LAS DFE co-exists with a LAS endemic equilibrium when the associated
reproduction number R0C is less than unity (R0C < 1). To check for the possibility of back-
ward bifurcation in the meningitis strain C-only model (3.25), the discriminant b21− 4a1c1 of
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quadratic (B.12), is set to zero and the result solved for the critical value of R0C (denoted
by R0C∗ < 1). This gives;
R0C∗ = 1−
b21
4a1k6k7(ν + ω + µ)
(3.26)
for which it can be shown that backward bifurcation occurs for values of R0C∗ such that
R0C∗ < R0C < 1. The epidemiological importance of the phenomenon of backward bi-
furcation is that, the requirement of having R0C < 1 is necessary, but not sufficient for
disease elimination. In this case, disease elimination will depend upon the initial sizes of the
sub-populations of the model.
Theorem 9 The disease free equilibrium, Ê2 of the meningitis strain C-only sub-model
(3.25), for special case ε = 0 is globally asymptotically stable whenever R0C ≤ 1. The
disease free equilibrium is given as Ê2 =
(
π(ω + µ)
µ(ν + µ+ ω)
,
πν
µ(ν + µ+ ω)
, 0, 0, 0
)
We can prove Theorem 9 using the approach in Section 3.3.3.
The equilibrium (E3) of the full meningitis model (3.1)
Let
E3 = (S∗∗, V ∗∗, C∗∗A , I∗∗A , R∗∗A , C∗∗C , I∗∗C , R∗∗C , C∗∗AC , I∗∗AC , R∗∗AC)
be the infection equilibrium of the full meningitis model (3.1). In this section, we present
some results of this equilibrium. First we show the existence of this equilibrium E3. We can
numerically show the existence of an equilibrium E3; however, for mathematical tractability
we make the following transformation, set β = max {βA, βC , βAC , βCA}, σ = min {σA, σC , σAC},
δ = min {δA, δC , δAC}, γ = min {γA, γC , γAC}, κ = min {κA, κC , κAC}, and let C = (CA +
CC + CAC), I = (IA + IC + IAC), and R = (RA + RC + RAC). Thus, we can show the

















Hence, the full meningitis model (3.1) reduces to the following.
dS
dt
= π + ωV + κR− λS − k1S
dV
dt
= νS − pλV − k2V
dC
dt
= λS + pλV − k3C (3.27)
dI
dt
= σC − k4I
dR
dt
= γI − k5R
where, k1 = ν + µ, k2 = ω + µ, k3 = σ + µ, k4 = γ + µ+ δ, k5 = κ+ µ, p = 1− ε.
Setting the right-hand-side of (3.27) to zero and solving the equations at steady state in












∗∗ + k2 + pν)




∗∗ + k2 + pν)
k3k4k5(λ∗∗ + k1)(pλ∗∗ + k2)− k3k4k5ων − λ∗∗κγ(pλ∗∗ + k2 + pν)
,
R∗∗ =
λ∗∗πγσ(pλ∗∗ + k2 + pν)
k3k4k5(λ∗∗ + k1)(pλ∗∗ + k2)− k3k4k5ων − λ∗∗κγ(pλ∗∗A + k2 + pν)







∗∗ + c2 = 0 (3.29)
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where
a2 = πk4k5p+ πk5pσ + πγpσ
b2 = πk2k4k5 + πk3k4k5p+ πk4k5pν + πk2k5σ + πk5pσν + πγσAk2
−βηπk4k5p− βπk5pσ (3.30)
c2 = k3k4(ν + ω + µ)(1−R0F )
and
R0F =
β(ω + µ+ pν)(ηk4 + σ)
k3k4(ν + ω + µ)
Using the approach in Section 3.3.3 we can prove the following results
Theorem 10 The meningitis model (3.27) has:
(i) a unique endemic equilibrium if c2 < 0 ⇐⇒ R0F > 1;
(ii) a unique endemic equilibrium if (b2 < 0 and c2 = 0) or b
2
2 − 4a2c2 = 0;
(iii) two endemic equilibrium if c2 > 0, b2 < 0 and b
2
2 − 4a2c2 > 0;
(iv) no endemic equilibrium otherwise.
Theorem 11 The disease free equilibrium, Ê3 of the meningitis model (3.27), for special
case ε = 0 is globally asymptotically stable whenever R0F ≤ 1. The disease free equilibrium
is given as Ê3 =
(
π(ω + µ)
µ(ν + µ+ ω)
,
πν
µ(ν + µ+ ω)




3.4 Analysis of the sub-model without co-infection (3.2)
3.4.1 Basic qualitative properties
Positivity and boundedness of solutions
Lemma 5 Let the initial data S(0) > 0, V (0) ≥ 0, CA(0) ≥ 0, IA(0) ≥ 0, RA(0) ≥ 0,
CC(0) ≥ 0, IC(0) ≥ 0, RC(0) ≥ 0. Then, the solutions (S(t), V (t), CA(t), IA(t), RA(t), CC(t),







The proof of Lemma 5 is given in Appendix B.3.
Invariant region
Analysis of the meningitis model without co-infection (3.2) will be carried out in the biological
feasible region




Lemma 6 The region D̂ is positively-invariant and attracting for meningitis model without
co-infection (3.2) with non-negative initial conditions in R8+.
The proof of Lemma 6 is given in Appendix B.3.
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3.4.2 Stability of the DFE of the meningitis model without co-
infection (3.2)
The meningitis model without co-infection (3.2) has a disease-free equilibrium obtained by
setting the right-hand sides of the equations in the model to zero and solving at CA = CC =
IA = IC = 0. Thus, the disease-free equilibrium is given by














µ(ν + ω + µ)
,
νπ
µ(ν + ω + µ)
, 0, 0, 0, 0, 0, 0
)
Theorem 12 The disease-free equilibrium E+0 of the meningitis model without co-infection
(3.2) is locally-asymptotically stable (LAS) if R̂0 < 1 and unstable if R̂0 > 1.
The computation of the reproduction number R̂0 is presented in Appendix B.4. The repro-
duction number R̂0 measures the average number of new infections generated by a single
infected person during his or her infectious period in a population that is fully susceptible.
Thus, the epidemiological implication of Theorem 12 above is that meningitis will be con-
trolled in the population without co-infection whenever R̂0 < 1 if the initial sizes of the sub
populations of the model are in the basin of attraction of the DFE (E+0 ).
Following the approach used for the analyzes of the full meningitis model (3.1) with co-
infection in Section 3.3 above, we can show the existence and stability of boundary equilibria,
bifurcation analysis for strains A-only and C-only models, and their global stabilities for
special case ε = 0. However, we do not show the proofs since their derivations are similar to
those provided previously in Section 3.3.3.
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3.5 Numerical Simulation and Discussion
In this section, we explore and analyze the full meningitis model (3.1) and the meningitis
model without co-infection (3.2) numerically, in order to see the dynamical behavior of the
solutions. In addition, we explore for the full meningitis model (3.1) two scenarios in which
the transmission of strain A is stronger in co-infected individuals, and when the transmission
of strain C is stronger in co-infected individuals. Using the baseline parameter values as
presented in Agusto & Leite (2019), except otherwise stated, we determine the respective
reproduction numbers R0A and R0C of each strain A and C.
3.5.1 Numerical simulation for the full meningitis model (3.1)
As discussed by Martcheva et al. (2007), when each strain can invade the other’s equilibrium
(R0A > 1 and R0C > 1), they are both expected to coexist in the population. However,
for models that allows super-infection (which is the process of a strain occuring after or on
top of an earlier infection by a different strain), strain replacement depends on the details
of competitive outcomes at the within-host level. This depends on the existence of some
difference in the mode of transmission between the two strains or within-host competitive
advantage of one of the strains. As presented in Figure 3.3(a) - 3.4(b), we explore the effect
of strain transmission probabilities of co-infected individuals (βAC and βCA), in the popu-
lation where the disease reproduction number of the two strains are equal and at endemic
(R0A = R0C > 1). Figure 3.3(a) depicts that, strain A will dominate in the population even
when the two strains have equal reproduction numbers. This result can be traced to the
transmission probability of strain A in co-infected individuals (βAC = 0.3345, βCA = 0), thus
driving out strain C and reducing the number of co-infected individuals to zero. Similarly,
in Figure 3.3(b), strain C dominates and drives out strain A and co-infected individuals
in the population given that the transmission probability of strain C through co-infected
individual is nonzero (βCA = 0.3345). Hence, the model (3.1) exhibits competitive exclusion
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(where by strain A drives out strain C, and vice-versa, at their equilibrium), due to exclusive
transmission of either strain A or strain C from co-infected individuals.




































































Figure 3.3: Simulation of the full model (3.1) showing total number of infected individuals when
R0A = R0C > 1, with (R0A = R0C = 4.20). Parameters are at baseline values. (a) Strain A is
transmitted in co-infected individuals, βAC > βCA, with (βAC = 0.3345, βCA = 0); (b) Strain C is
transmitted in co-infected individuals, βCA > βAC , with (βAC = 0, βCA = 0.3345).
Allowing nonzero transmission probabilities for both strains in the co-infected individuals
informs us of the dynamic of co-existence of the two strain in the population. As presented in
Figure 3.4(a), a nonzero transmission probability of strain C in co-infected individuals βCA
enables its competition with strain A in the populace. Strain A dominates in the population
but does not drive strain C to extinction. Similarly, Figure 3.4(b) depicts the co-existence
of the two strains with strain C having the higher tranmission probability when both strains
have nonzero transmission probabilities.
74


































































Figure 3.4: Simulation of the full model (3.1) showing total number of infected individuals when
R0A = R0C > 1, with (R0A = R0C = 4.20). Parameters are at baseline values. (a) Strain A
has higher transmission in co-infected individuals, than strain C βAC > βCA, with (βAC = 0.3345,
βCA = 0.2245); (b) Strain C has higher transmission in co-infected individuals, than strain A
βCA > βAC , with (βAC = 0.2245, βCA = 0.3345).
In order to answer the question of the possibilities of co-existence of the two strains in
the population, we also explore cases when (R0A > R0C > 1 and R0C > R0A > 1) in
Figure 3.5(a) through Figure 3.8(b). Figure 3.5(a) shows a similar result to Figure 3.3(a),
where-by strain A dominates and drive strain C into extinction, due to the increase in
the reproduction number of strain A and the only transmission probability in co-infected
individuals (βAC) leading to transmission of strain A. However, Figure 3.5(b) indicates a
trade-off mechanism (the process whereby a strain with a lower reproduction number can
co-exist with a strain with a higher reproduction number). Given that strain A has the
highest reproduction number, the model exhibits a trade-off mechanism whereby strain A
and C and co-infected individuals co-exist in the population. This mechanism occurs due
to the transmission probabilities of strain A and C in co-infected individuals (βAC = 0,
βCA = 0.3345), i.e. there is no possibilities of strain A been transmitted in the co-infected
individuals. In other words, the model exhibits a trad-off mechanism when strain A has a
between-host advantage in reproduction number, but strain C has a within-host advantage in
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the co-infected individuals. This enables strain C to dominate in the population at endemic
equilibrium.




































































Figure 3.5: Simulation of the full model (3.1) showing total number of infected individuals when
R0A > R0C > 1, with (R0A = 6.72,R0C = 4.20). Parameters are at baseline values except for βA =
0.5345. (a) Strain A is transmitted in co-infected individuals, βAC > βCA, with (βAC = 0.3345,
βCA = 0); (b) Strain C is transmitted in co-infected individuals, βCA > βAC , with (βAC = 0,
βCA = 0.3345).
In addition, increasing the transmission probabilities for the co-infected individuals changes
the dynamics of the system. We observe a coexistence of the two strains, with the strain
having the highest probability in co-infected individuals dominating but not driving the
other strain into extinction. For example, as shown in Figure 3.6(b), the two strains co-exist
while strain C is the dominant strain due to its high transmission probability βCA = 0.3345
compare to βAC = 0.2245.
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Figure 3.6: Simulation of the full model (3.1) showing total number of infected individuals when
R0A > R0C > 1, with (R0A = 6.72,R0C = 4.20). Parameters are at baseline values except
for βA = 0.5345. (a) Strain A has higher transmission than strain C in co-infected individuals,
βAC > βCA, with (βAC = 0.3345, βCA = 0.2245); (b) Strain C has higher transmission than strain
A in co-infected individuals, βCA > βAC , with (βAC = 0.2245, βCA = 0.3345).
Figure 3.7(a) - Figure 3.8(b) present a similar result in Figure 3.5(a) - Figure 3.6(b). In
general, the transmission probabilities of the two strains in co-infected individuals has a
greater impact in the competition and dominance of each strain in the population. In cases
where one strain has the between-host advantage (reproduction number advantage) but it
also has a zero transmission probability from co-infected hosts (within-host disadvantage),
we see oscillatory behavior (Figure 3.5b and 3.7a).
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Figure 3.7: Simulation of the full model (3.1) showing total number of infected individuals when
R0C > R0A > 1, with (R0A = 4.20,R0C = 7.58). Parameters are at baseline values except for
βC = 0.4683 and σC = 0.0313. (a) Strain A is transmitted in co-infected individuals, βAC > βCA,
with (βAC = 0.3345, βCA = 0) (b) Strain C is transmitted in co-infected individuals, βCA > βAC ,
with (βAC = 0, βCA = 0.3345).




































































Figure 3.8: Simulation of the full model (3.1) showing total number of infected individuals when
R0C > R0A > 1, with (R0A = 4.20,R0C = 7.58). Parameters are at baseline values except for
βC = 0.4683 and σC = 0.0313. (a) Strain A has higher transmission than strain C in co-infected
individuals, βAC > βCA, with (βAC = 0.3345, βCA = 0.2245) (b) Strain C has higher transmission
than strain A in co-infected individuals, βCA > βAC , with (βAC = 0.2245, βCA = 0.3345).
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3.5.2 Numerical simulation of the meningitis model without co-
infection (3.2)
We also explore the dynamical behavior of the model without co-infection model as given in
equation (3.2). For the case when R0A > R0C > 1, strain A dominates in the population
while strain C is driven to extinction as shown in Figure 3.9(a). Similarly, Figure 3.9(b)
depicts the extinction of strain A when R0C > R0A > 1. Hence, the model without co-
infection will exhibit competitive exclusion when R0A > R0C > 1 (strain A drives out strain
C) or when R0C > R0A > 1 (strain C drives out strain A). Thus, the dominance of a strain
in the population depends on the strain with the highest reproduction number. However, in
the case whereby the two strains have the same reproduction number at their endemic state,
they are expected to both co-exist, hence, dominance of a strain will depend on the initial
size of their population.



































































Figure 3.9: Simulation of the model with no co-infection (3.2). (a) Total number of infected
individuals when R0A > R0C > 1, with (R0A = 6.72,R0C = 4.20). Parameters are at baseline
values except for βA = 0.5345 (b) Total number of infected individuals when R0C > R0A > 1, with
(R0A = 4.20,R0C = 7.98). Parameters are at baseline values except for βC = 0.6345.
We simulate the dynamics of the model without co-infection, with equal reproduction num-
ber. Figure 3.10(a) shows that strain A dominates in the population due to its initial pop-
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ulation size which is greater than strain C initial population size. Similarly, Figure 3.10(b)
depicts strain C as the dominant strain, which is as a result of its initial population size.






































































Figure 3.10: Simulation of the model without co-infection (3.2), when R0A = R0C > 1, with
(R0A = R0C = 4.20). Parameters are at baseline values. (a) Showing total number of infected
individuals when the initial population of strain A individuals is as twice as strain C population.
(b) Showing total number of infected individuals when the initial population of strain C individuals
is as twice as strain A population.
3.5.3 Conclusions
In this study, we developed a deterministic mathematical model to study the transmission
dynamics of two strains of meningitis (strain A and strain C) in the population, using
ordinary differential equations. We consider three different scenarios (i-ii. full model: when
a particular strain is stronger in transmission than the other in co-infected individuals, iii.
the model without co-infection). The main results obtained from the theoretical analysis
and simulation are summarized below.
(i) The full meningitis model and the model without co-infection has a locally asymp-
totically stable disease-free equilibrium whenever R0 < 1 and unstable if R0 > 1 (i.e
meningitis strain A can be curtailed when R0A < 1, similarly meningitis strain C can
be curtailed when R0C < 1).
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(ii) The meningitis strain A-only model exhibit backward bifurcation, where the stable
disease-free equilibrium co-exists with a stable endemic equilibrium when reproduction
number of strain A only is less than unity. The numerical values of the coefficients (a
and b) are found.
(iii) The DFE of the meningitis strain A-only model with the special case ε = 0 (no vaccine
efficacy) is globally asymptotically stable whenever the reproduction number R0A is
less than unity;
(iv) Numerical simulation shows that for the scenario where we set the transmission prob-
ability in co-infected individuals of a strain to zero, the co-infection model exhibit
competitive exclusion (a strain driving out the other strain into extinction when both
are at endemic), due to the relative transmission probabilities of the two strains in
co-infected individuals. Biologically, this can be explained by the existence of some
difference in the mode of transmission between the two strains or within-host com-
petitive advantage of one of the strains. However, for the scenario where we set the
transmission probability in co-infected individuals of a strain greater than the other
(transmission probability of neither strain is equal to zero), we observed a trade-off
mechanism which enables co-existence of the two strains. Regardless of the greatest
reproduction number value of each strain, the strain with the highest transmission
probability in co-infected individual will dominate in the population but not drive the
other strain into extinction.
(v) The model without co-infection exhibits competitive exclusion when R0A > R0C > 1
(strain A drives out strain C) or when R0C > R0A > 1 (strain C drives out strain
A). However, our results show that when the two strains have the same reproduction
number at their endemic state, they are expected to both co-exist, but the dominance




Bacterial meningitis remains a global public health challenge, with the highest burden being
in the African meningitis belt. According to World Health Organization (WHO) (2018),
vaccination is the most effective way of preventing the disease in the population. This study
presents the formulation, analysis, and simulation of numerous, novel mathematical models
to examine the effect of vaccination in controlling meningitis, specifically utilizing data from
Nigeria to parameterize the models.
In Chapter 2, we present a non-impulsive model and an impulsive model to study the effect
of constant and pulse vaccination in eradicating Neisseria meningitidis in the population.
Overall, in this chapter, our results show that vaccinating with a lower rate slowly protects
and prevent the disease transmission in contrast to when a high vaccination rate is used;
this protect more people at a faster rate. Furthermore, our results depict that meningitis
can be effectively controlled in the population using an imperfect vaccine with an efficacy
greater than 75% and high vaccine coverage rate of at least 85%. In addition, numerical
simulation of the impulsive model depict that final infected population size is lower when
applying the impulsive vaccination strategy compare with the scenario without vaccination.
Thus, disease burden in the population decreases with increasing vaccination pulses.
In the final chapter, we focus on the dynamics of meningitis A and meningitis C in the
presence of vaccination under different scenarios. We present a full model with co-infection
and also a sub-model without co-infection. For the scenario where we set the transmission
probability of a strain from co-infected individuals to zero, our results depict that the co-
82
infection model exhibit competitive exclusion (a strain driving the other strain into extinction
when both are at endemic), due to the difference in transmission probabilities of the two
strains. Biologically, this can be explained by the existence of some difference in the mode
of transmission between the two strains or within-host competitive advantage of one of
the strains. However, for the scenario in which we set the transmission probability of a
strain greater than the other (transmission probability of neither strain is equal to zero),
we observed a trade-off mechanism which enables co-existence of the two strains. In this
case, regardless of the greatest reproduction number value of each strain, the strain with the
highest transmission probability in co-infected individual will dominate in the population
but not drive the other strain into extinction.
The model without co-infection exhibit competitive exclusion when R0A > R0C > 1 (strain
A drives out strain C) or when R0C > R0A > 1 (strain C drives out strain A). However, our
results show that when the two strains have the same reproduction number at their endemic
state, they are expected to both co-exist, but the dominance of a strain will depend on the
initial size of their population.
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Appendix A
A.1 Coefficients of polynomial (2.12)
A7 = δ
5β2η2EE
A6 = (−ηβδ4(ηβk4EE + ηβk2EE + 2EEσβ − δEEσ − σδ + 3ηβEEk3))
A5 = (−δ3(−σ2δ2 + δηβk2σ + δηβk4σ + δηβEEσπ + δηβk2EEσ + δηβk1σ
+δηβEEσν + 2δηβEEσk3 + 2δηβσk3 + δβEEσ
2 + δβσ2 + δηβk4EEσ − 3η2β2k4EEk3
−3η2β2k23EE + η2β2κγCEE − η2β2k2k4EE − 3η2β2k2EEk3 − 2ηβ2k4EEσ − 2ηβ2k2EEσ
−EEσ2β2 − 4ηβ2EEσk3))
A4 = (−δ2(−η2β2κγIσEE + δηβκγCσ − 3η2β2k3κγCEE − 2ηβ2κγCEEσ
+δ2k4σ
2 + β2k4EEσ
2 + δ2νσ2 − δβk4σ2 − δηβk23σ − δβσ2k3 + δ2σ2k3
+δ2k1σ
2 + δ2k2σ
2 − δηβk4k1σ − δηβk23EEσ − δηβk2k4EEσ − δηβk2EEσν









−2δηβEEπσk3 − δβEEσ2π − δηβk4EEσπ − δηβk2EEσπ − δβEEσ2ν − δβk2EEσ2
−δβEEσ2k3 − 2δηβk2EEσk3 − 2δηβk1σk3 − δηβk2k1σ − δηβk2k4σ − δηβk4EEσν
−2δηβk4EEσk3 − 2δηβEEνσk3 − 2δηβk4σk3 − δβk1σ2 − δβk2σ2 − 2δηβk2σk3))
A3 = (δ(−δβEEσ2πk3 + δβκγCσ2 + 2δηβk3κγCsigma+ δηβκγCk1σ − 4ηβ2k3κγCEEσ
−beta2κγCEEσ2 − δβk4EEπσ2 − 2η2β2k3κγIσEE − δ2ηβσ2π + δη2β2k4EEσπ
−δηβk23EEσπ + 2δη2β2EEπσk3 + δ2k4σ2π + δ2k1σ2π + δ2k2σ2π − 2δηβk4EEπσk3






2 − δ2νσ2ω − δβk4EEσ2k3 − 2δηβk4k1σk3
−δηβk23k4EEσ − δβk2k1σ2 − δβk4k1σ2 − δβk1σ2k3 − δβk2k4σ2 − δβk4σ2k3
−δβk2σ2k3 − 2δηβk2k4σk3 − δηβk2k23σ − δηβk23k4σ − δβk2EEσ2ν − δβk2EEσ2k3
−2δηβk2k4EEσk3 − δβEEσ2νk3 − δβk2k4EEσ2 − δβk4EEνσ2 + β2k2k4EEσ2 + β2k2EEσ2k3
−2δηβk4EEνσk3 − δηβk23EEσν − δηβk2k4k1σ − δηβk23k1σ − δηβk2k4EEσν





3EEσ − δηβk2k4EEσπ − 2δηβk2EEπσk3
+δ2σ2πk3 + δηβκγCEEνσ + 2δηβ
2EEσ2π − 3η2β2k23κγCEE − 2ηβ2κγIσ2EE
−δβk2EEσ2π + δηβκγIσ2))
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−delta2k4πσ2k1 + betaηk3πσ2δ2 − πσ3δEEβ2 + 2k2k3k4πσEEβηδ − k2k3δ2πσ2
−2ηδπσ2k4EEβ2 − δ2k3k4πσ2 − delta2k3πσ2k1 − δ2k4νσ2k1 + δk3k4πσ2EEβ
+βηδ2πσ2k4 − k2δ2k4πσ2 − k2k33k4β2η2EE − k2k3k4β2σ2EE + 2k2k3k4βηδk1σ













3k4σδEEβη − δ2k3k4νσ2 + δk23k4βηk1σ + δk3k4βσ2k1
+δk23k4νσEEβη + δk3k4νσ
2EEβ − δ2k3k4σ2k1 + k2δ2ωσ2ν − k2δ2νσ2k1 − δ2k3νσ2k1
+δ2k4ωσ
2ν + βπσ3δ2 − βκγIσ3δ − βηδκγIσ2k1 + η2k33κγCEEβ2
+2ηk23κγCEEβ
2σ − βηk23κγCσδ − 2νσEEβηk3κγCδ − νσ2EEβηδκγI
+σ2κγCk3EEβ
2 − βσ2κγCk3δ − βσ2κγCδk1 + κγIσ3EEβ2 − 2βηk3κγCδk1σ
+η2k23κγIσEEβ
2 + 2ηk3κγIσ
2EEβ2 − βηk3κγIσ2δ − nuσ2EEβκγCδ)





+σk2δk4k1k3 + σδk2k4k1ν − σβk2k4k1k3 − σδk4νωk3 + σδk2k1νk3 + σδk2k4νk3
+σδk4k1νk3 − σδk2k4νω − σδk2νωk3 − σ2βδπEEν − σ2βδk1π − σ2βδk4π
+σ2k4πEEβ
2 − σηβδk4πk3 − σβk2k4EEπk3 + 2σηk4EEπk3β2 − σηβδk1πk3 − σηβδk4πEEν
−σηβδk3πEEν + σδk2k4k1π + σδk2k1πk3 + σδk2k4πk3 − σηβδk4k1π − ηβk2k23k4EEπ
+k23k4EEπβ
2η2 + σ2βκγIk1 + σ
2βκγIEEν + σηβk3κγIk1 + σβk3κγCEEν + σδk4k1πk3
−ηβk2k23k4k1 − ηβk2k23k4EEν))
A0 = −k4σ2(1−R0),
where EE = 1− ε.
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Appendix B
B.1 Proof of Theorem 6
To apply the Centre Manifold theory, it is convenient to carry out the following change of vari-
ables. Let S = x1, V = x2, CA = x3, IA = x4, and RA = x5. Thus, N = x1 + x2 + x3 + x4 + x5.
Furthermore, by using the notation X = (x1, x2, x3, x4, x5)
T , the Meningitis strain A-only model




= f1 = π + ωx2 + kAx5 − λAx1 − k1x1
dx2
dt
= f2 = νx1 − pλAx2 − k2x2
dx3
dt
= f3 = λAx1 + pλAx2 − k3x3 (B.1)
dx4
dt
= f4 = σAx3 − k4x4
dx5
dt
= f5 = γAx4 − k5x5
with the associated force of infection given by:
λA =
βA(ηx3 + x4)
x1 + x2 + x3 + x4 + x5
(B.2)
Considering the case when R0A = 1. Suppose that β∗A is chosen as the bifurcation parameter
(obtained by solving for βA = β
∗
A from R0A = 1) given below as:
β∗A =
k3k4(ν + ω + µ)
(pν + ω + µ)(ηk4 + σA)
(B.3)
The jacobian of the system (B.1), evaluated at disease-free (E0) = (x∗1, x∗2, 0, 0, 0) with βA = β∗A
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denoted by J (E0, β∗A), is given by:































































0 0 σA −k4 0
0 0 0 γA −k5

(B.4)
Eigenvectors of J (E0, β∗A)
The Jacobian of (B.1), evaluated at the DFE (E0) with βA = β∗A denoted by J (E0, β∗A) has a right






























, v2 > 0, v5 =
νκAv2
k1k5





Computation of bifurcation coefficient a and b
It can be shown, by computing the associated non-zero partial derivative of F (X) (evaluated at













(ηw3 + w4)Q (B.5)
where;
Q = p(v2 − v3)(w1x2 + w3x2 + w4x2 + w5x2 − w2x1) + (v1 − v3)(w2x1 + w3x2 + w4x1 + w5x1 − w1x2)



























2). Since the coefficient b is always
positive, it follows that the meningitis strain A-only (3.12) will undergo backward bifurcation if the
coefficient a, given by (B.5) is positive.
B.2 Strain C-only Boundary Equilibrium (E2)
Here we will establish the conditions for the existence of an equilibrium for which strain C-only is
endemic in the population. At the infection equilibria E2 = (S∗∗, V ∗∗, C∗∗C , I∗∗C , R∗∗C ) the meningitis
model (3.1) is reduced to the system of equation below,
dS
dt
= π + ωV + κCRC − λCS − k1S
dV
dt
= νS − pλCV − k2V
dCC
dt
= λCS + pλCV − k6CC (B.7)
dIC
dt
= σCCC − k7IC
dRC
dt
= γCIC − k8RC
where: k1 = ν + µ, k2 = ω + µ, k6 = σC + µ, k7 = γC + µ+ δC , k8 = κC + µ, p = 1− ε.





























C + k2 + pν)
k6k7k8(λ∗∗C + k1)(pλ
∗∗





C + k2 + pν)
k6k7k8(λ∗∗C + k1)(pλ
∗∗





C + k2 + pν)
k3k4k5(λ∗∗C + k1)(pλ
∗∗
C + k2)− k6k7k8ων − λ∗∗C κCγC(pλ∗∗C + k2 + pν)
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The total population is obtained by summing up the sub-population as below








C + k2 + ν) + (λ
∗∗
C πk7k8 + λ
∗∗




C + k2 + pν)
k6k7k8(λ∗∗C + k1)(pλ
∗∗
C + k2)− k6k7k8ων − λ∗∗C κCγC(pλ∗∗C + k2 + pν)
(B.10)
Substituting equation (B.9) and (B.10) into (B.8) gives,
λ∗∗C =
λ∗∗C βC(ηπk7k8 + πσCk8)(pλ
∗∗
C + k2 + pν)
πk6k7k8(pλ∗∗C + k2 + ν) +
(
λ∗∗C πk7k8 + λ
∗∗




(pλ∗∗C + k2 + pν)
(B.11)
Further simplification of (B.11) shows that the positive equilibria of the model (B.7) satisfy the





C + c1 = 0 (B.12)
where
a1 = πk7k8p+ πk8σCp+ πγCσCp
b1 = πk2k7k8 + πk6k7k8p+ πk7k8pν + πk2k8σC + πk8σCpν + πγCσCk2
−βCηπk7k8p− βCπk8σCp (B.13)
c1 = πk2k6k7k8 + πk6k7k8ν − βCηπk2k7k8 − βCηπk7k8pν − βCπk2k8σC − βCπk8σCpν
In order to write the expression of c1 in form of R0C , we set c1 > 0, then
πk2k6k7k8 + πk6k7k8ν > βCηπk2k7k8 + βCηπk7k8pν + βCπk2k8σC + βCπk8σCpν
k2k6k7k8 + k6k7k8ν > βCηk2k7k8 + βCηk7k8pν + βCk2k8σC + βCk8σCpν
Substituting k2 = ω + µ results to,
k6k7(ω + µ+ ν) > βC(ηk7 + σC)(ω + µ+ pν) (B.14)
So that
R0C =
βC(ω + µ+ pν)(ηk7 + σC)
k6k7(ν + ω + µ)
< 1
Hence,
c1 ≡ k6k7(ν + ω + µ)(1−R0C)
Thus, the positive endemic equilibria of the meningitis strain C-only model are obtained by solving
the quadratic equation (B.12) and substituting the results (positive values of λ∗∗C ) into equation
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where a1, b1, c1 are defined as in equation (B.13) above.
The quadratic equation (B.12) above can be analyzed for the possibility of multiple endemic equi-
libria whenever R0C < 1. It should be noted that the coefficient a1, of the quadratic equation
(B.12) is always positive; and the constant term c1, is negative (positive) whenever R0C is greater
(less) than unity.
B.3 Analysis of the meningitis model without co-infection (3.2)
B.3.1 Basic qualitative properties
We will explore the basic qualitative properties of the meningitis model without co-infection (3.2)
in this section.
Positivity and boundedness of solutions
For the meningitis model without co-infection (3.2) to be epidemiologically meaningful, it is im-
portant to prove that all its state variables are non-negative for all time t ≥ 0. In other words,
solutions of the model system (3.2) with non-negative initial data will remain non-negative for all
time t > 0.
Lemma 7 Let the initial data S(0) > 0, V (0) ≥ 0, CA(0) ≥ 0, IA(0) ≥ 0, RA(0) ≥ 0, CC(0) ≥ 0,
IC(0) ≥ 0, RC(0) ≥ 0. Then, the solutions (S(t), V (t), CA(t), IA(t), RA(t), CC(t), IC(t), RC(t)) of





Proof. Let t2 = sup{t > 0 : S(t) > 0, V (t) > 0, CA(t) > 0, IA(t) > 0, RA(t) > 0, CC(t) > 0, IC(t) >
0, RC(t) > 0 ∈ [0, t]}. Thus, t2 > 0. It follows from the first equation of the system (3.2), that
dS
dt




+ (λA + λC + νA + µ)S ≥ 0
Multiplying by Integrating factor I.F, exp
{∫ t2

















[λA(ψ) + λC(ψ)] dψ + (ν + µ)t
}
≥ C






[λA(ψ) + λC(ψ)] dψ
}
> 0.
It can similarly be shown that V (t) > 0, CA(t) > 0, IA(t) > 0, RA(t) > 0, CC(t) > 0, IC(t) >
0, RC(t) > 0 for all t > 0.
Invariant region
Consider the biological feasible region




Lemma 8 The region D̂ defined by (B.17) is positively-invariant and attracting for model (3.2)
with non-negative initial conditions in R8+.
Proof. Let [S(t), V (t), CA(t), IA(t), RA(t), CC(t), IC(t), RC(t)] ∈ R8+, be the solution of model
(3.2) with non-negative initial conditions. The rate of change of the total population is obtained
by adding up the compartment of the system (3.2) to give
dN
dt
= π − µN − δAIA − δcIC ≤ π − µN (B.18)
Since, dNdt ≤ π − µN , it follows that
dN






+ µN = π (B.19)
Using the integrating factor method, so that equation (B.19) can be written as
d(Neµt) = πeµtdt


























In particular, N(t) ≤ πµ , if N(0) ≤
π
µ . Thus, every solution of the model (3.2) with initial conditions
in D̂ remains there for t > 0. Thus, D̂ is a positive-invariant. Hence, it is sufficient to consider the
dynamics of the flow generated by (3.2) in D̂. In this region, the model is said to be mathematically
and epidemiologically well posed (Hethcote, 2000). Thus, every solution of the meningitis model
without co-infection (3.2) with initial conditions in D̂ remains in D̂ for all t > 0.
B.4 Stability of the DFE of the meningitis model without co-
infection (3.2)
The linear stability of E+0 can be established using the next generation operator method. Using
the infected compartment, matrices F and V , for the transmission matrix (new infection) and the








0 0 0 0










k3 0 0 0
−σA k4 0 0
0 0 k6 0
0 0 −σC k7

(B.21)
Where k3 = σA + µ, k4 = γA + µ+ δA, k6 = σC + µ, k7 = γC + µ+ δC and P
+ = S+ + (1− ε)V +.
It follows that the reproduction number of the meningitis model (3.2) is given by
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where ρ is the spectral radius (highest eigenvalue) of the matrix FV −1 and N+ = S+ + V +.













+ + (1− ε)V +]
k6k7N+
(B.23)
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